Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository with detailed results at https://github.com/lhncbc/CRI/tree/master/regCTG

Study Counts

Type	Study_count
Total_Studies	2617
interventional	2291
Observational	300
Registry	26

Studies over Time

```

Interventional Trials

Intervention Type

intervention_type	Study_Count
Drug	1310
Drug\|placebo	143
Drug\|Radiation	118
Biological\|Drug	107
Biological	82
Radiation	75
Drug\|Other	59
Procedure	48
Drug\|Procedure	43
Other	35
Biological\|Drug\|Other	21
Device	18
Drug\|Procedure\|Radiation	18
Behavioral	13
Biological\|Drug\|placebo	13
Biological\|Drug\|Radiation	11
Biological\|Other	11
Diagnostic Test	10
Drug\|Other\|placebo	9
Drug\|Other\|Procedure	9
Drug\|Other\|Radiation	8
Drug\|placebo\|Radiation	8
Other\|Procedure	8
Procedure\|Radiation	8
Biological\|placebo	7
Device\|Drug	7
Biological\|Radiation	6
Other\|Radiation	6
Combination Product	5
Other\|Procedure\|Radiation	5
Dietary Supplement	4
Behavioral\|Other\|Procedure	3
Biological\|Other\|Radiation	3
Diagnostic Test\|Drug	3
Drug\|Genetic\|Other	3
Drug\|Other\|Procedure\|Radiation	3
Genetic	3
Behavioral\|Drug\|placebo	2
Biological\|Dietary Supplement\|Drug	2
Biological\|Drug\|Other\|placebo	2
Biological\|Drug\|Other\|Radiation	2
Biological\|Other\|Procedure\|Radiation	2
Device\|Drug\|Radiation	2
Device\|Other	2
Dietary Supplement\|Drug	2
Drug\|Genetic\|Other\|Procedure	2
Behavioral\|Drug\|Other\|placebo	1
Behavioral\|Drug\|Other\|Procedure	1
Behavioral\|Radiation	1
Biological\|Combination Product\|Drug\|Other	1
Biological\|Device	1
Biological\|Device\|Drug\|Radiation	1
Biological\|Diagnostic Test	1
Biological\|Drug\|Genetic\|Other	1
Biological\|Drug\|Other\|Procedure	1
Biological\|Drug\|placebo\|Radiation	1
Biological\|Drug\|Procedure	1
Biological\|placebo\|Radiation	1
Biological\|Procedure	1
Combination Product\|Drug	1
Combination Product\|Other	1
Device\|Drug\|Other	1
Device\|Drug\|Other\|Procedure	1
Device\|Drug\|Procedure\|Radiation	1
Device\|Other\|Radiation	1
Device\|Procedure	1
Device\|Radiation	1
Diagnostic Test\|Drug\|Other	1
Diagnostic Test\|Other\|Procedure	1
Dietary Supplement\|Drug\|Radiation	1
Dietary Supplement\|placebo	1
Drug\|Genetic	1
Drug\|Genetic\|Other\|placebo	1
Drug\|Genetic\|Other\|Procedure\|Radiation	1
Drug\|Genetic\|Procedure	1
Drug\|Other\|placebo\|Procedure	1

Count of Studies by Intervention (normalized and mapped)

Intervention_type	intervention	Study_count	Date of First Study
Drug	carboplatin	355	2010
Drug	paclitaxel	244	2010
Drug	cisplatin	233	2014
Drug	pemetrexed	210	2014
Drug	docetaxel	192	2014
placebo	placebo	158	2010
Drug	gemcitabine	137	2014
Drug	pembrolizumab	133	2015
Drug	erlotinib	114	2011
Radiation	radiotherapy	105	2016
Other	laboratory biomarker analysis	102	2014
Drug	bevacizumab	98	2017
Drug	nivolumab	91	2015
Drug	gefitinib	66	2011
Drug	durvalumab	54	2018
Drug	cetuximab	48	2009
Drug	gemcitabine hydrochloride	44	2017
Drug	vinorelbine	40	2010
Drug	osimertinib	36	2018
Drug	atezolizumab	35	2016
Drug	erlotinib hydrochloride	34	2017
Drug	chemotherapy	33	2017
Biological	ipilimumab	33	2014
Drug	nab-paclitaxel	31	2014
Other	quality-of-life assessment	31	2014
Other	pharmacological study	29	2013
Drug	pemetrexed disodium	26	2017
Radiation	stereotactic body radiation therapy	24	2010
Drug	afatinib	21	2013
Drug	etoposide	20	2014
Other	questionnaire administration	20	2014
Drug	crizotinib	19	2016
Drug	erlotinib [tarceva]	19	2010
Drug	anlotinib	16	2018
Drug	ramucirumab	16	2010
Drug	celecoxib	15	2007
Radiation	radiation	14	2018
Radiation	sbrt	14	2018
Procedure	surgery	14	2009
Procedure	therapeutic conventional surgery	14	2018
Drug	tremelimumab	14	2018
Drug	vinorelbine tartrate	14	2011
Drug	alectinib	13	2016
Drug	avelumab	13	2017
Procedure	conventional surgery	13	2018
Drug	bortezomib	12	2008
Drug	icotinib	12	2017
Drug	necitumumab	12	2019
Drug	selumetinib	12	2018
Drug	sintilimab	12	2018
Drug	brigatinib	11	2018
Drug	cyclophosphamide	11	2009
Drug	vorinostat	11	2009
Other	best supportive care	10	2011
Drug	bibw 2992	10	2009
Radiation	3-dimensional conformal radiation therapy	9	2014
Drug	azd9291	9	2016
Drug	bevacizumab [avastin]	9	2009
Drug	olaparib	9	2016
Radiation	stereotactic body radiation therapy (sbrt)	9	2018
Drug	sunitinib	9	2008
Drug	trametinib	9	2017
Drug	pazopanib	8	2009
Drug	pemetrexed/cisplatin	8	2010
Drug	sorafenib	8	2009
Procedure	adjuvant therapy	7	2006
Drug	azd6244	7	2010
Drug	ceritinib	7	2015
Other	ct-scan	7	2009
Drug	everolimus	7	2016
Drug	gemcitabine/carboplatin	7	2010
Radiation	intensity-modulated radiation therapy	7	2014
Drug	kg	7	2019
Drug	m^2	7	2016
Procedure	neoadjuvant therapy	7	2019
Drug	oxaliplatin	7	2019
Drug	atezolizumab (mpdl3280a), an engineered anti-pd-l1 antibody	6	2017
Drug	bibf 1120	6	2011
Drug	cabozantinib	6	2018
Drug	cediranib maleate	6	2010
Drug	concurrent chemotherapy	6	2019
Drug	dexamethasone	6	2010
Drug	entinostat	6	2016
Drug	gemcitabine/cisplatin	6	2010
Other	immunohistochemistry staining method	6	2008
Drug	irinotecan hydrochloride	6	2007
Drug	ldk378	6	2014
Drug	medi4736	6	2014
Drug	nintedanib	6	2014
Other	pet	6	2005
Procedure	positron emission tomography	6	2014
Drug	standard care	6	2019
Drug	veliparib	6	2016
Drug	abemaciclib	5	2015
Drug	anamorelin hcl	5	2018
Drug	anlotinib hydrochloride	5	2019
Drug	apatinib	5	2017
Drug	arq 197	5	2012
Drug	auy922	5	2013
Drug	bavituximab	5	2010
Drug	canakinumab	5	2019
Drug	cobimetinib	5	2018
Other	educational intervention	5	2012
Drug	erlotinib hcl	5	2009
Genetic	gene expression analysis	5	2007
Radiation	hypofractionated radiation therapy	5	2014
Drug	inc280	5	2014
Drug	irinotecan	5	2009
Drug	lenvatinib	5	2019
Drug	lorlatinib	5	2018
Drug	m2	5	2012
Drug	mk-3475	5	2014
Drug	oleclumab	5	2016
Drug	paclitaxel / carboplatin	5	2010
Drug	palbociclib	5	2017
Biological	pembrolizumab 200 mg	5	2019
Drug	pf-00299804	5	2010
Genetic	protein expression analysis	5	2007
Radiation	split-course radiotherapy	5	2019
Drug	temozolomide	5	2000
Radiation	thoracic radiotherapy	5	2020
Biological	trastuzumab	5	2017
Drug	vandetanib	5	2014
Drug	ac0010	4	2016
Drug	alimta	4	2007
Drug	anlotinib/docetaxel	4	2018
Procedure	az7550	4	2014
Drug	bi 754091	4	2018
Drug	binimetinib	4	2019
Drug	bkm120	4	2014
Drug	cabozantinib s-malate	4	2018
Drug	camrelizumab	4	2019
Drug	cc-486	4	2014
Biological	cixutumumab	4	2010
Other	clinical observation	4	2014
Procedure	computed tomography	4	2014
Drug	dasatinib	4	2016
Drug	docetaxel/cisplatin	4	2010
Drug	egf816	4	2014
Drug	enzastaurin	4	2007
Drug	erlotinib (tarceva)	4	2007
Behavioral	exercise	4	2017
Drug	fludarabine	4	2019
Radiation	fludeoxyglucose f 18	4	2009
Dietary Supplement	folic acid	4	2010
Drug	fruquintinib	4	2015
Drug	gemcitabine / carboplatin	4	2015
Drug	gemcitabine / cisplatin	4	2015
Drug	imatinib mesylate	4	2010
Other	immunoenzyme technique	4	2006
Drug	mpdl3280a	4	2014
Other	observation	4	2020
Drug	paclitaxel albumin-stabilized nanoparticle formulation	4	2012
Drug	pdr001	4	2016
Drug	pemetrexed / carboplatin	4	2015
Drug	pemetrexed / cisplatin	4	2015
Drug	pemetrexed 500 mg	4	2013
Drug	pemetrexed/carboplatin	4	2019
Drug	pertuzumab	4	2015
Other	pet/ct	4	2018
Drug	pf-02341066	4	2007
Procedure	pharmacokinetic sampling - az5140	4	2014
Procedure	pharmacokinetic sampling - az5140/az7550	4	2014
Procedure	pharmacokinetic sampling - azd9291	4	2014
Radiation	proton beam radiation therapy	4	2014
Behavioral	questionnaire	4	2011
Drug	ribociclib	4	2014
Drug	s-1	4	2011
Drug	single low dose cyclophosphamide	4	2009
Radiation	stereotactic body radiotherapy	4	2017
Radiation	stereotactic body radiotherapy (sbrt)	4	2019
Drug	tak-788	4	2019
Drug	tarceva	4	2009
Biological	tecemotide (l-blp25)	4	2009
Drug	temsirolimus	4	2010
Drug	tipifarnib	4	2018
Drug	vinorelbine ditartrate	4	2010
Dietary Supplement	vitamin b12	4	2010
Drug	vitamin c	4	2016
Drug	NA	3	2018
Drug	40 mg	3	2018
Drug	abi-007	3	2011
Drug	alflutinib	3	2018
Drug	amifostine trihydrate	3	1999
Drug	arq 197/erlotinib	3	2010
Drug	axitinib	3	2017
Drug	azd3759	3	2017
Drug	azd4547	3	2013
Drug	azd6738	3	2019
Drug	azd9291 80 mg	3	2015
Drug	azd9291 tablet dosing	3	2014
Other	best available therapy	3	2017
Drug	bexarotene	3	2006
Procedure	biopsy	3	2018
Other	blood sample	3	2018
Drug	capecitabine	3	2013
Drug	carboplatin/paclitaxel	3	2018
Drug	cisplatin 75 mg	3	2013
Drug	cisplatin 75 mg/m^2	3	2013
Drug	cp-751,871	3	2005
Drug	cs-7017	3	2010
Drug	dacomitinib	3	2011
Drug	danvatirsen	3	2016
Drug	darbepoetin alfa	3	2006
Drug	durvalumab (medi4736)	3	2019
Procedure	ebus-tbna	3	2009
Drug	endostar	3	2016
Drug	epacadostat	3	2017
Drug	exemestane	3	2016
Drug	exisulind	3	2004
Radiation	fdg-pet	3	2015
Other	flow cytometry	3	2006
Drug	fludeoxyglucose f-18	3	2018
Drug	gefitinib 250 mg	3	2018
Drug	gm-csf	3	2013
Radiation	image guided radiation therapy	3	2013
Drug	ipi	3	2018
Drug	itraconazole	3	2015
Drug	m7824	3	2018
Other	medical chart review	3	2012
Drug	metformin	3	2017
Drug	metformin hydrochloride	3	2014
Drug	mm-121	3	2009
Drug	motexafin gadolinium	3	2005
Genetic	mutation analysis	3	2010
Drug	nimotuzumab	3	2018
Drug	paclitaxel 200 mg	3	2013
Drug	paclitaxel 200 mg/m^2	3	2013
Drug	paclitaxel/carboplatin	3	2010
Drug	panitumumab	3	2009
Biological	pegfilgrastim	3	2012
Drug	pemetrexed 500 mg/m^2	3	2013
Drug	placebo/docetaxel	3	2011
Drug	platinum	3	2013
Drug	porfimer sodium	3	2016
Drug	poziotinib	3	2017
Drug	rad001	3	2007
Drug	saline solution	3	2019
Biological	shr-1210	3	2018
Drug	sirolimus	3	2012
Drug	sitravatinib	3	2019
Drug	sorafenib (nexavar, bay43-9006)	3	2009
Radiation	stereotactic radiosurgery	3	2016
Radiation	stereotactic radiotherapy	3	2009
Drug	suramin	3	2012
Drug	tcm	3	2011
Drug	tepotinib	3	2019
Drug	thalidomide	3	2017
Drug	tirapazamine	3	2001
Drug	topotecan	3	2015
Drug	trastuzumab emtansine	3	2014
Drug	triapine	3	2004
Drug	tyrosine kinase inhibitor	3	2016
Drug	vinblastine sulfate	3	2017
Drug	zd1839	3	2005
Drug	zd6474	3	2003
Drug	zoledronic acid	3	2013
Radiation	18 f fluorodeoxyglucose	2	2009
Drug	ab928	2	2020
Drug	abr-217620	2	2005
Drug	abt-751	2	2003
Drug	abx-egf	2	2005
Other	adjuvant	2	2017
Biological	adv	2	2016
Biological	adv/hsv-tk	2	2016
Drug	afatinib (bibw 2992)	2	2009
Drug	afatinib dimaleate	2	2015
Biological	ak105	2	2019
Biological	aldesleukin	2	2014
Biological	alt-803	2	2015
Drug	anamorelin hydrochloride	2	2018
Drug	anlotinib/pemetrexed	2	2018
Biological	antigen-specific dth	2	2019
Drug	antroquinonol	2	2014
Drug	aprepitant	2	2015
Drug	apricoxib	2	2008
Drug	apx005m	2	2018
Drug	atezolizumab (mpdl3280a) [tecentriq], an engineered anti-pdl1 antibody	2	2015
Biological	avastin	2	2014
Drug	avastin (bevacizumab)	2	2016
Drug	axl1717	2	2011
Drug	azacitidine	2	2013
Drug	azd4635	2	2016
Drug	azd5363	2	2016
Drug	azd9150	2	2018
Drug	bi 2536	2	2014
Drug	bi 754111	2	2018
Drug	bms-690514	2	2010
Drug	bms-986205	2	2016
Drug	bpi-7711	2	2019
Drug	capmatinib	2	2019
Drug	carboplatin auc6	2	2018
Drug	carboplatin)	2	2009
Drug	carboplatin/gemcitabine	2	2007
Biological	cemiplimab	2	2017
Drug	chemo	2	2018
Drug	chidamide	2	2018
Biological	cik cell	2	2012
Drug	cis-platinum	2	2012
Drug	cisplatin injection	2	2020
Drug	cisplatin/carboplatin	2	2011
Device	computed tomography perfusion imaging	2	2017
Biological	control dth	2	2019
Other	counseling intervention	2	2011
Drug	cpt-11	2	2006
Biological	cs1001 monoclonal antibody	2	2018
placebo	cs1001 placebo	2	2018
Other	cytology specimen collection procedure	2	2014
Drug	d-0316	2	2019
Drug	dabrafenib	2	2011
Drug	dacomitinib (pf-00299804)	2	2011
Drug	dalotuzumab	2	2008
Drug	day	2	2012
Drug	decitabine	2	2004
Biological	dendritic cell immunotherapy	2	2019
Drug	denosumab	2	2014
Drug	dexamethasone 4 mg	2	2019
Other	diagnostic laboratory biomarker analysis	2	2011
Drug	dnib0600a	2	2013
Drug	docetaxel (taxotereâ®)	2	2007
Drug	docetaxel 75 mg	2	2016
Drug	docetaxel/carboplatin	2	2016
Drug	docetaxel/pemetrexed	2	2008
Biological	dribble vaccine	2	2009
Drug	ds-1205c	2	2018
Combination Product	durvalumab / monalizumab	2	2018
Combination Product	durvalumab / oleclumab	2	2018
Drug	ec20	2	2012
Drug	ef5	2	2014
Drug	egfr	2	2017
Biological	enoblituzumab	2	2015
Drug	ensartinib	2	2016
Drug	entrectinib	2	2015
Drug	eribulin mesylate	2	2006
Radiation	external beam radiation therapy	2	2012
Device	flt-pet	2	2016
Dietary Supplement	folic acid 350-1000 î¼g	2	2019
Drug	gdc-0941	2	2009
Drug	gefitinib (iressa)	2	2009
Drug	glumetinib	2	2019
Drug	gtx-024	2	2011
Biological	hla-a*2402restricted urlc10, cdca1,	2	2013
Drug	hm61713	2	2012
Drug	hsp90 inhibitor auy922	2	2013
Biological	hsv-tk	2	2016
Drug	hydroxychloroquine	2	2009
Radiation	hypofractionated radiotherapy	2	2009
Drug	ibrutinib	2	2014
Drug	ifosfamide	2	2005
Device	ima_detect	2	2018
Radiation	image-guided radiation therapy	2	2018
Drug	iressa	2	2005
Biological	isis 3521	2	1999
Drug	itacitinib	2	2018
Drug	ixabepilone	2	2009
Drug	ixabepilone, 32 mg	2	2008
Drug	jnj-61186372	2	2019
Biological	kn046	2	2019
Drug	l-dos47	2	2013
Drug	lapatinib	2	2011
Drug	lazertinib	2	2019
Procedure	lobectomy	2	2017
Procedure	local consolidation therapy	2	2018
Drug	lxh254	2	2017
Drug	ly2603618	2	2009
Biological	ly2875358	2	2012
Drug	ly900003	2	2002
Drug	methylprednisolone	2	2013
Drug	midazolam	2	2014
Drug	mifepristone	2	2015
Drug	min	2	2013
Drug	minocycline	2	2011
Drug	mk-2206	2	2011
Drug	ml intravenous solution	2	2019
Combination Product	monalizumab	2	2018
Drug	nab paclitaxel	2	2020
Procedure	needle biopsy	2	2010
Biological	neo-pv-01	2	2017
Drug	niraparib	2	2017
Drug	nivolumab 10 mg	2	2019
Drug	nivolumab 10 mg/ml intravenous solution	2	2019
Biological	nk immunotherapy	2	2016
Device	novottf-100l	2	2008
Drug	onartuzumab	2	2013
Drug	ono-4538	2	2015
Drug	oral vinorelbine	2	2008
Drug	osi-906	2	2010
Drug	osimertinib mesylate tablets	2	2018
Drug	paclitaxel injection	2	2020
Drug	patupilone	2	2005
Biological	pembrolizumab 2 mg	2	2016
Biological	pembrolizumab 2 mg/kg	2	2016
Drug	pemetrexed (alimta)	2	2009
Device	pet scan imaging	2	2015
Drug	pf-06463922	2	2013
Drug	pf-3512676	2	2002
Other	pharmacogenomic studies	2	2012
Other	pharmacokinetic study	2	2018
Drug	photodynamic therapy	2	2013
Radiation	photon beam radiation therapy	2	2012
Radiation	photon therapy	2	2009
Drug	pi-88	2	2005
placebo	placebo azd9291 80 mg	2	2015
placebo	placebo capsule	2	2013
placebo	placebo for olaparib	2	2020
placebo	placebo gefitinib 250 mg	2	2018
Drug	platinum-based chemotherapy	2	2017
Drug	plb1001	2	2020
Drug	ponatinib	2	2013
Drug	pralatrexate	2	2000
Radiation	proton radiotherapy	2	2007
Radiation	proton therapy	2	2009
Procedure	radiofrequency ablation	2	2007
Radiation	radiolabeled (99tc) ec-dg (ethylenedicysteine-deoxyglucose)	2	2009
Biological	ras peptide cancer vaccine	2	2007
Biological	recombinant ephb4-hsa fusion protein	2	2017
Drug	recombinant human endostatin	2	2010
Drug	regn2810	2	2018
Drug	regn2810/chemo/ipi	2	2018
Drug	regorafenib	2	2018
Other	rehabilitation education	2	2017
Behavioral	rehabilitation training	2	2017
Drug	retifanlimab	2	2018
Biological	romiplostim	2	2019
Radiation	sabr	2	2018
placebo	saline placebo for pembrolizumab	2	2016
Drug	sar408701	2	2019
Drug	savolitinib	2	2019
Drug	selinexor	2	2017
Drug	selpercatinib	2	2020
Drug	simvastatin	2	2014
Procedure	single photon emission computed tomography	2	2016
Biological	sintilimab injection	2	2020
Drug	sndx-275	2	2008
Drug	sorafenib tosylate	2	2007
Drug	spartalizumab	2	2019
Drug	standard chemotherapy	2	2013
Procedure	standard follow-up care	2	2013
Procedure	stereotactic ablative radiotherapy (sabr)	2	2015
Drug	sunitinib malate	2	2008
Other	supportive care	2	2016
Procedure	surgical resection	2	2019
Drug	tagrisso	2	2016
Drug	talactoferrin	2	2009
Drug	tarceva (erlotinib hcl)	2	2004
Drug	tarceva (trademark) (erlotinib hcl, osi-774)	2	2004
Drug	taxol	2	2005
Drug	taxotere	2	2004
Biological	tg4010	2	2017
Procedure	therapeutic thoracoscopy	2	1999
Radiation	thoracic irradiation	2	2020
Radiation	thoracic radiation therapy (trt)	2	2018
Procedure	thoracic surgical procedure	2	2017
Drug	tislelizumab	2	2020
Drug	tisotumab vedotin	2	2017
Drug	tki	2	2018
Drug	tlk286	2	2004
Drug	topotecan hydrochloride	2	2006
Biological	toripalimab	2	2019
Drug	tq-b3139	2	2019
Drug	trastuzumab deruxtecan (ds-8201a)	2	2019
Drug	valacyclovir	2	2016
Biological	vegfr2	2	2009
Drug	velcade	2	2006
Drug	vemurafenib	2	2017
Drug	vidaza	2	2014
Procedure	video-assisted surgery	2	1999
Drug	vinorelbine (navelbine)	2	2008
Drug	vinorelbine/cisplatin	2	2011
Drug	vistusertib	2	2017
Dietary Supplement	vitamin b12 1000 î¼g	2	2019
Device	voc analysis	2	2018
Radiation	whole-brain radiotherapy	2	2015
Drug	x-396 (ensartinib)	2	2016
Drug	xl647	2	2007
Drug	ym155	2	2010
Drug	zimberelimab	2	2020
Drug	[11c]osimertinib	1	2018
Drug	[14c]pf00299804	1	2009
Radiation	[18f]fluoroglucose(fdg)	1	2015
Drug	01	1	2002
Drug	1 year follow-up;	1	2020
Drug	100 mg	1	2014
Drug	100mg	1	2014
Drug	160 mg	1	2020
Drug	1650-g vaccine	1	2008
Drug	18f-arag	1	2019
Drug	18f-fdg	1	2015
Procedure	18f-fdg-pet scan	1	2014
Drug	18f-fludeoxyglucose (18f-fdg)	1	2013
Drug	18f-fluoromisonidazole	1	2012
Drug	18f-fmiso	1	2013
Drug	18f-fpprgd2	1	2013
Drug	18f-fspg	1	2015
Other	18f-pd-l1	1	2018
Drug	1st line chemotherapy	1	2006
Other	2-deoxy-2-[18f]fluoro-d-glucose (fdg)	1	2007
Radiation	2.5 gy	1	2018
Radiation	2.5 gy/fraction	1	2018
Drug	2503	1	2017
Procedure	2d vats lobectomy	1	2019
Other	3’-deoxy-3’-[18f]fluorothymidine (flt)	1	2007
Radiation	3-d crt)	1	2014
Radiation	3-dimensional conformal radiation therapy (3d-crt)	1	2017
Radiation	34 gy in a single fraction	1	2013
Diagnostic Test	3d-ex	1	2017
Radiation	3d conform radiotherapy	1	2009
Procedure	3d vats lobectomy	1	2019
Diagnostic Test	4-d ct scan	1	2017
Drug	40mg	1	2018
Other	4d-ct scan	1	2012
Device	4d pet-ct	1	2011
Drug	5-flourouracil	1	2018
Drug	5-fluorouracil)	1	2013
Radiation	54gy 18gy	1	2013
Radiation	54gy 18gy/fr. x 3 fractions	1	2013
Drug	6-hydroxymethylacylfulvene	1	1999
Radiation	60 gy rt	1	2007
Radiation	60gy (12 x 5 fr.s)	1	2013
Radiation	60gy (7.5gy x 8fr.)	1	2013
Other	68ga-nota-ae105 pet	1	2016
Other	68ga-nota-ae105 pet/ct	1	2016
Drug	7-hydroxystaurosporine	1	2002
Radiation	70 gy in 20 fractions over 4 weeks	1	2015
Radiation	74 gy rt	1	2007
Diagnostic Test	89zr-avelumab pet	1	2018
Drug	89zr-pembrolizumab	1	2016
Device	89zr-pembrolizumab pet	1	2016
Drug	a) standard maintenance programme group, pembrolizumab 200mg, every 3 weeks, for a total of 2 years of follow-up	1	2020
Drug	a) standard maintenance programme group, pembrolizumab 200mg, every 3 weeks, for a total of 2 years of follow-up/follow-up for 1 year;	1	2020
Procedure	a: radiotherapy alone	1	2005
Drug	ab154	1	2020
Drug	abbv-181	1	2019
Drug	abbv-184	1	2020
Drug	abbv-368	1	2019
Drug	abbv-927	1	2019
Drug	abexinostat	1	2018
Drug	abi-007 (abraxane)	1	2006
Drug	abi-007 (abraxane)/carboplatin	1	2006
Biological	abi-007/carboplatin/trastuzumab	1	1999
Drug	abiraterone acetate	1	2016
Drug	abp 215	1	2013
Drug	abraxane	1	2017
Drug	abraxane (induction)	1	2014
Drug	abraxane (maintenance)	1	2014
Drug	abraxane / carboplatin	1	2017
Drug	abt-869	1	2008
Drug	abt-869 .25 mg	1	2007
Drug	abt-869 .25 mg/kg	1	2007
Drug	abt-869 0.10 mg	1	2007
Drug	abt-869 0.10 mg/kg	1	2007
Drug	abx	1	2013
Drug	abx/with cisplatin	1	2013
Drug	ac	1	2017
Drug	acalabrutinib	1	2015
Radiation	accelerated conformational radiotherapy	1	2001
Radiation	accelerated fraction	1	2014
Drug	acetaminophen	1	2019
Drug	acridine carboxamide	1	1999
Diagnostic Test	act-hla	1	2017
Drug	active comparator (erlotinib)	1	2011
Drug	acy-241	1	2015
Drug	acyclovir	1	2013
Genetic	ad-ccl21-dc .05 x 07	1	2018
Genetic	ad-ccl21-dc 1 x 07	1	2018
Genetic	ad-ccl21-dc 3 x 07	1	2018
Genetic	ad-ccl21-dc exd	1	2018
Biological	ad-magea3	1	2016
Biological	ad100-gp96ig-hla a1	1	2007
Other	adaptated physical activity	1	2019
Drug	adjuvant bevacizumab	1	2005
Drug	adjuvant chemotherapy (taxol	1	2009
Drug	adjuvant chemotherapy (taxol/carboplatin)	1	2009
Drug	adxs-503	1	2019
Drug	afatinib - 1a	1	2013
Drug	afatinib - 1b	1	2013
Biological	aflibercept	1	2008
Drug	aflibercept (ziv-aflibercept, ave0005, vegf trap, zaltrapâ®)	1	2007
Drug	ag-013736	1	2008
Drug	ag-013736 (axitinib)	1	2008
Radiation	aggressive thoracic radiotherapy	1	2018
Drug	akt inhibitor mk2206	1	2011
Drug	albumin-bound paclitaxel	1	2007
Drug	albumin-bound paclitaxel, carboplatin, toripalimab	1	2020
Drug	albumin paclitaxel	1	2010
Drug	albumin paclitaxel/carboplatin	1	2010
Drug	alclometasone cream	1	2011
Drug	alectnib	1	2018
Drug	alflutinib mesylate (ast2818) 80mg	1	2018
Drug	alflutinib mesylate (ast2818) 80mg//40 mg/ placebo	1	2018
Drug	alimta injectable product	1	2019
Drug	alimta/taxotere	1	2007
Drug	alimtaâ®	1	2006
Device	alk qpcr assay	1	2013
Drug	alkotinib	1	2018
Biological	allogeneic tumour lysate (melcancervac)	1	2007
Drug	alt-803 / atezolizumab	1	2017
Drug	alt-803 / avelumab	1	2017
Drug	alt-803 / nivolumab	1	2017
Drug	alt-803 / pembrolizumab	1	2017
Drug	amg 102	1	2010
Drug	amg 102/erlotinib	1	2010
Drug	amg 386	1	2012
placebo	amg 386 placebo	1	2012
Drug	amg 479, everolimus, panitumumab	1	2010
Drug	amg 510	1	2020
Drug	amg 655	1	2007
placebo	amg 655 placebo	1	2007
Drug	amg 951 (rhapo2l	1	2007
Drug	amg 951 (rhapo2l/trail)	1	2007
Biological	amg820	1	2016
Biological	amg820/pembrolizumab	1	2016
Drug	amifostine	1	2004
Drug	aminocamptothecin colloidal dispersion	1	1999
Drug	anastrozole	1	2016
Procedure	anatomical segmentectomy, lobectomy	1	2018
Procedure	anatomical segmentectomy, lobectomy/bilobectomy	1	2018
Drug	anlotinib hydrochloride capsule	1	2020
Drug	anlotinib, oral capsule	1	2019
Drug	anlotinib/icotinib	1	2018
Drug	anlotinib/with osimertinib	1	2019
Drug	anlotinib/with pemetrexed/carboplatin	1	2018
Biological	anti-ny-eso-1 tcr transduced t cells	1	2017
Drug	anti-pd-l1 monoclonal antibody mpdl3280a	1	2015
Biological	anti-pd1	1	2019
Biological	anti-pd1 antibody-activated tils	1	2019
Drug	antibody tf2	1	2010
Other	antitumor drug screening assay	1	2006
Drug	ap	1	2017
Drug	ap/ac	1	2017
Drug	apatinib 250mg	1	2017
Drug	apatinib 500mg	1	2017
Drug	apatinib 750mg	1	2017
Drug	apatinib mesylate tablet	1	2017
Drug	apatinib mesylate tablet/with s-1 capsules	1	2017
Drug	apatinib/with vinorelbine	1	2018
Drug	apatinibï¼ˆ250mg	1	2019
Drug	apatinibï¼ˆ250mg/dï¼‰/with egfr-tki	1	2019
Drug	apg-1252	1	2019
Procedure	apheresis	1	2009
Drug	approved anti-pd-1 inhibitor	1	2017
Drug	apricoxib/erlotinib	1	2008
Drug	arm a	1	2018
Drug	arm b	1	2018
Radiation	arm1 (hypofractionated radiotherapy)	1	2017
Drug	armodafinil	1	2011
Drug	asa404	1	2008
Drug	ask120067	1	2018
Drug	asn007 rd	1	2018
Drug	asn007: ascending doses	1	2018
Biological	ast-vac2	1	2017
Drug	at-101	1	2007
Drug	at-101/docetaxel	1	2007
Drug	at13387	1	2012
Drug	atezolizumab-bevacizumab	1	2019
Drug	atezolizumab (mpdl3280a), an engineered anti-programmed death-ligand 1 (anti-pd-l1) antibody	1	2015
Drug	atezolizumab 1200 mg in 20 ml injection	1	2019
Biological	atl001	1	2019
Drug	atovaquone	1	2015
Drug	atra	1	2009
Drug	auranofin	1	2012
Biological	autologous dendritic cell-adenovirus ccl21 vaccine	1	2008
Biological	autologous dendritic cell cancer vaccine	1	2005
Drug	autologous dendritic cells pulsed with antigen	1	2019
Genetic	autologous genetically modified adp-a2m4cd8 cells	1	2019
Biological	autologous genetically modified t cells, magea10á¶œâ·â¹â¶t	1	2015
Biological	autologous tcm cells immunotherapy	1	2018
Biological	autologous wt1-tcrc4 gene-transduced cd8-positive tcm	1	2015
Biological	autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes	1	2015
Biological	av-299	1	2009
Biological	av-299 / gefitinib	1	2009
Drug	avastin in combination with paclitaxel	1	2016
Drug	avastin in combination with paclitaxel/carboplatin	1	2016
Drug	avastinâ®	1	2017
Drug	avelumab (msb0010718c)	1	2018
Drug	avelumab 1200 mg in combination with gemcitabine	1	2017
Drug	avelumab 1200 mg in combination with gemcitabine/cisplatin	1	2017
Drug	avelumab 1200 mg in combination with pemetrexed	1	2017
Drug	avelumab 1200 mg in combination with pemetrexed/carboplatin	1	2017
Drug	avelumab 800 mg in combination with gemcitabine	1	2017
Drug	avelumab 800 mg in combination with gemcitabine / cisplatin.	1	2017
Drug	avelumab 800 mg in combination with pemetrexed	1	2017
Drug	avelumab 800 mg in combination with pemetrexed / carboplatin	1	2017
Drug	avitinib maleate	1	2018
Drug	axitinib (ag-013736)	1	2018
Drug	azacitidine 30mg	1	2006
Drug	azacitidine 30mg/m2	1	2006
Drug	azacitidine 40mg	1	2006
Drug	azacitidine 40mg/m2	1	2006
Drug	azd2014	1	2014
Drug	azd2171	1	2005
Drug	azd4205	1	2018
Drug	azd4785	1	2017
Drug	azd6244 / erlotinib	1	2010
Drug	azd8931	1	2014
Drug	azd9291 40 mg	1	2015
Drug	azd9291 80 mg/40 mg	1	2015
Drug	azd9291 80 mg/40 mg / placebo	1	2014
Drug	azd9291 tablets	1	2014
Drug	b) improvement maintenance programme group, pembrolizumab 200mg, every 6 weeks, for a total of 2 years of follow-up	1	2020
Drug	b) improvement maintenance programme group, pembrolizumab 200mg, every 6 weeks, for a total of 2 years of follow-up/1 year follow-up;	1	2020
Drug	b: cbdca	1	2005
Drug	b: cbdca/radiotherapy	1	2005
Drug	b12	1	2008
Drug	bavituximab/paclitaxel/carboplatin	1	2008
Drug	bay 43-9006	1	2007
Drug	bay 43-9006 (sorafenib)	1	2004
Drug	bay59-8862 (cytotoxic taxane)	1	2002
Drug	bcd-100	1	2017
Drug	becatecarin	1	2000
Behavioral	behavioral intervention	1	2018
Drug	belinostat, carboplatin, paclitaxel	1	2011
Drug	belloxa	1	2010
Drug	belotaxel	1	2010
Drug	belotecan	1	2009
Drug	berzosertib	1	2015
Other	best standard of care (bsc)	1	2005
Other	best support treatment	1	2010
Other	best supportive care (maintenance)	1	2014
Dietary Supplement	beta-glucan	1	2008
Drug	bevacizumab-eu	1	2015
Drug	bevacizumab-pfizer	1	2015
Drug	bevacizumab (avastin)	1	2005
Drug	bevacizumab / pemetrexed	1	2009
Drug	bevacizumab / pemetrexed / carboplatin	1	2009
Drug	bevacizumab 15 mg	1	2010
Drug	bevacizumab 15 mg/kg	1	2010
Drug	bevacizumab 7.5 mg	1	2010
Drug	bevacizumab 7.5 mg/kg	1	2010
Drug	bevacizumab in combination with paclitaxel	1	2016
Drug	bevacizumab in combination with paclitaxel/carboplatin	1	2016
Drug	bevacizumab with chemotherapy, pleur-xtm catheter placement	1	2005
Drug	bevacizumab, oxaliplatin, pemetrexed	1	2005
Drug	bevacizumab,erlotinib	1	2008
Drug	bevacizumab/erlotinib	1	2015
Drug	bevacizumab/pemetrexed/cisplatin	1	2013
Drug	bexarotene (targretin)	1	2005
Drug	bexarotene with carboplatin	1	2002
Drug	bexarotene with carboplatin/paclitaxel	1	2002
Drug	bgb324	1	2016
Biological	bi 1361849	1	2017
Drug	bi 6727	1	2009
Drug	bi 695502	1	2014
Drug	bi 836845	1	2014
Drug	bi 836880	1	2018
Drug	bi 891065	1	2017
Drug	bibf 1120 es high dose	1	2014
Drug	bibf 1120 es low dose	1	2014
Drug	bibf 1120 h	1	2009
Drug	bibf 1120 h / docetaxel h	1	2009
Drug	bibf 1120 h / docetaxel m	1	2009
Drug	bibf 1120 l	1	2009
Drug	bibf 1120 l / docetaxel m	1	2009
Drug	bibf 1120 m	1	2009
Drug	bibf 1120 m / docetaxel h	1	2009
Drug	bibf 1120 m / docetaxel m	1	2009
Drug	bibf 1120/docetaxel	1	2008
Drug	bibw 2992 ma2 20mg	1	2008
Drug	bibw 2992 ma2 20mg/day	1	2008
Drug	bibw 2992 ma2 40mg	1	2008
Drug	bibw 2992 ma2 40mg/day	1	2008
Drug	bibw 2992 ma2 50mg	1	2008
Drug	bibw 2992 ma2 50mg/day	1	2008
Drug	bibw 2992 qd	1	2008
Drug	bibw2992	1	2008
Drug	bibw2992 / paclitaxel	1	2008
Drug	biib022 with paclitaxel	1	2009
Drug	biib022 with paclitaxel/carboplatin	1	2009
Procedure	bilobectomy	1	2018
Drug	bind-014	1	2013
Drug	bind-014 (docetaxel nanoparticles for injectable suspension)	1	2014
Drug	bio-11006	1	2018
Drug	bio-11006/standard of care	1	2018
Drug	bio 300 oral suspension	1	2015
Procedure	biopsy of a metastatic lesion.	1	2013
Procedure	biopsy samples	1	2005
Procedure	biospecimen collection	1	2017
Drug	bisphosphates	1	2008
Drug	bkm120/erlotinib	1	2011
Other	blood	1	2012
Diagnostic Test	blood-sampled	1	2018
Biological	blood-stage infection of p. vivax	1	2016
Other	blood collection	1	2019
Procedure	blood draw	1	2018
Procedure	blood oxygen level dependent imaging	1	2019
Procedure	blood sample for methylation analysis	1	2010
Other	blood withdrawal	1	2016
Drug	bms-813160	1	2019
Drug	bms-986253	1	2019
Drug	bnp7787	1	2004
Procedure	bone marrow aspiration from the iliac crest	1	2015
Drug	bosutinib	1	2017
Drug	bpi-15086	1	2016
Drug	bpi-7711 capsule	1	2017
Drug	bpi-9016m	1	2016
Radiation	brachytherapy	1	2005
Device	breath actuated nebulizer	1	2017
Other	breath collection	1	2019
Radiation	breath holding	1	2006
Procedure	breath test	1	2013
Device	bronchoscopic thermal vapor ablation	1	2017
Drug	bryostatin 1	1	2000
Drug	bsc	1	2012
Drug	ca	1	2018
Drug	ca/nivolumab	1	2018
Drug	cabazitaxel	1	2013
Drug	cabazitaxel-xrp6258 (3-week cycle)	1	2011
Drug	cabazitaxel-xrp6258 (5-week cycle)	1	2011
Drug	cabiralizumab	1	2018
Drug	cabozantinib 20 mg	1	2019
Drug	cabozantinib 40 mg	1	2019
Drug	cabozantinib 60 mg	1	2019
Drug	calcitriol	1	2003
Drug	calcitriol / docetaxel	1	2003
Drug	camrelizumab/with albumin-bound paclitaxel/cisplatin	1	2020
placebo	canakinumab matching placebo	1	2018
Drug	canfosfamide hydrochloride	1	2002
Device	capp-seq	1	2016
Biological	car-t cells	1	2018
Combination Product	car-t combining pd-1 knockout	1	2018
Drug	carboplatin-based	1	2013
Drug	carboplatin-based chemotherapy	1	2008
Drug	carboplatin-nab-paclitaxel	1	2017
Drug	carboplatin-paclitaxel	1	2017
Drug	carboplatin-taxol-radiotherapy	1	2005
Drug	carboplatin (area under the concentration curve [auc] 6)	1	2008
Drug	carboplatin (auc 5)	1	2010
Drug	carboplatin (auc 6)	1	2010
Drug	carboplatin (dose level 1)	1	2018
Drug	carboplatin (dose level 2)	1	2018
Drug	carboplatin (induction)	1	2014
Drug	carboplatin (palaplatin)	1	2008
Drug	carboplatin ,pemetrexed	1	2018
Drug	carboplatin / pemetrexed / atezolizumab	1	2019
Drug	carboplatin / pemetrexed / atezolizumab / bevacizumab	1	2019
Drug	carboplatin // gemcitabine // docetaxel //cisplatin	1	2007
Drug	carboplatin area under the curve (auc)5	1	2016
Drug	carboplatin auc	1	2019
Drug	carboplatin auc 2	1	2012
Drug	carboplatin auc 5 mg	1	2013
Drug	carboplatin auc 5 mg/ml/min	1	2013
Drug	carboplatin auc 6	1	2017
Drug	carboplatin auc 6 mg	1	2013
Drug	carboplatin auc 6 mg/ml/min	1	2013
Drug	carboplatin auc2	1	2018
Drug	carboplatin injection	1	2020
Drug	carboplatin paclitaxel	1	2018
Drug	carboplatin pemetrexed	1	2017
Drug	carboplatin therapy	1	2008
Drug	carboplatin, 5 mg	1	2008
Drug	carboplatin, 6 mg	1	2008
Drug	carboplatin, pemetrexed	1	2008
Drug	carboplatin, pemetrexed/bevacizumab	1	2008
Drug	carboplatin,pemetrexed	1	2018
Drug	carboplatin/ paclitaxel	1	2018
Drug	carboplatin/gemcitabine, carboplatin/taxol	1	2005
Drug	carboplatin/nab paclitaxel	1	2019
Drug	carboplatin/paclitaxel (cp)	1	2004
Drug	carboplatin/paclitaxel/medi-575	1	2010
Drug	carboplatine	1	2005
Drug	carboxyamidotriazole	1	1999
Behavioral	carevive cps	1	2017
Drug	carotuximab (trc105)	1	2017
Drug	cb-839	1	2016
Drug	cbp501	1	2009
Drug	cbp501 / cisplatin / pemetrexed	1	2009
Drug	cc-223, erlotinib	1	2012
Drug	cc-223, oral azacitidine	1	2012
Drug	cc-5013	1	2005
Biological	cccr-nk92 cells	1	2018
Drug	ccrt arm without consolidation chemotherapy	1	2006
Drug	cddp	1	2005
Drug	cdp791 10mg	1	2005
Drug	cdp791 10mg/kg	1	2005
Drug	cdp791 20mg	1	2005
Drug	cdp791 20mg/kg	1	2005
Drug	cdx-1127	1	2011
Drug	cediranib	1	2017
Drug	cemiplimab regn2810	1	2017
Behavioral	center for epidemiological studies depression scale	1	2015
Radiation	centrally located lung tumor	1	2009
Drug	centrum	1	2012
Drug	ceritinib (ldk378)	1	2015
Drug	cetuximab / cisplatin / vinorelbine	1	2005
Drug	cetuximab / gefitinib	1	2005
Drug	cetuximab / platinum / gemcitabine	1	2005
Drug	cetuximab 250 mg	1	2009
Drug	cetuximab 250 mg/m^2	1	2009
Drug	cetuximab 500 mg	1	2009
Drug	cetuximab 500 mg/m^2	1	2009
Drug	cetuximab in combination with carboplatin	1	2009
Drug	cetuximab in combination with carboplatin/gemcitabine	1	2009
Drug	cetuximab/platinum-based doublet chemotherapy	1	2009
Biological	cg8123	1	2004
Other	chemo-irradiation	1	2004
Radiation	chemoradiotherapy	1	2016
Other	chemoradiotherapy regimen between pc	1	2011
Other	chemoradiotherapy regimen between pc/pe	1	2011
Radiation	chemoradiotherapy with integrated boost dose	1	2016
Drug	chemort	1	2018
Other	chemotherapy (arm a only)	1	2019
Other	chemotherapy concurrent with radiotherapy	1	2019
Other	chemotherapy/radiotherapy	1	2009
Procedure	chemotherapy/surgery	1	2006
Procedure	chest radiotherapy	1	1999
Diagnostic Test	chest xray	1	2018
Drug	chinese traditional medicine xh1	1	2018
Drug	ci-1040	1	2002
Drug	ci 1033	1	2005
Drug	cilengitide	1	2009
Drug	cilengitide, radiochemotherapy	1	2010
Drug	cisplatin-gemzar	1	2005
Drug	cisplatin-navelbine-radiotherapy	1	2005
Drug	cisplatin (dose level 1)	1	2018
Drug	cisplatin (dose level 2)	1	2018
Drug	cisplatin (dose level 3)	1	2018
Drug	cisplatin (dose level 4)	1	2018
Drug	cisplatin / docetaxel	1	2008
Drug	cisplatin / docetaxel / enoxaparin	1	2008
Drug	cisplatin / pemetrexed	1	2009
Drug	cisplatin / vinorelbine	1	2005
Drug	cisplatin followed by gemcitabine	1	2007
Drug	cisplatin intercalating gefitinib	1	2017
Drug	cisplatin iv	1	2009
Drug	cisplatin phase 1	1	2007
Drug	cisplatin phase 2	1	2007
Drug	cisplatin with concomitant radiotherapy 66 gy (total dose)	1	2008
Drug	cisplatin)	1	2007
Drug	cisplatin, dexamethasone,vitamin b12, folic acid	1	2010
Drug	cisplatin, docetaxel	1	2008
Drug	cisplatin, gemcitabine	1	2010
Drug	cisplatin, ifosfamide, gemcitabine	1	2008
Drug	cisplatin, vinorlebine, cetuximab	1	2009
Drug	cisplatin.	1	2017
Drug	cisplatin/ etoposide	1	2018
Drug	cisplatin/carboplatin-based	1	2013
Drug	cisplatin/carboplatin,pemetrexed	1	2018
Drug	cisplatin/docetaxel	1	2007
Drug	cisplatin/gemcitabine	1	2018
Drug	cisplatin/pemetrexed	1	2015
Procedure	cisplatin/radiation therapy	1	2007
Drug	cisplatin/vinorelbine	1	2007
Drug	cisplatin; etoposide; radiation therapy; docetaxel; neulasta	1	2008
Drug	cisplatine	1	2005
Drug	cisplatine, etoposide, cetuximab	1	2009
Drug	cisplatinum (50mg	1	2012
Drug	cisplatinum (50mg/m2) iv (in the vein) on day 1/day 8 of a 28-day cycle for 2 cycles	1	2012
Device	ck	1	2009
Drug	ck-101	1	2016
Drug	ck-301 (cosibelimab)	1	2017
Drug	cln-081	1	2019
Drug	cmp-001	1	2018
Drug	cofetuzumab pelidotin	1	2019
Procedure	cognitive assessment	1	2016
Drug	combination carboplatin	1	2004
Drug	combination carboplatin/paclitaxel	1	2004
Drug	combination chemotherapy (pemetrexed	1	2007
Drug	combination chemotherapy (pemetrexed / cisplatin)	1	2007
Biological	combination nivolumab	1	2017
Biological	combination nivolumab/ipilimumab	1	2017
Drug	combination of arixtra with chemotherapy	1	2007
Drug	combination of nktr-214	1	2016
Drug	combination of nktr-214 / nivolumab	1	2016
Drug	combination of nktr-214 / nivolumab / ipilimumab	1	2016
Drug	combination of sorafenib	1	2009
Drug	combination of sorafenib/everolimus	1	2009
Drug	combo pbf-509 (160 mg)	1	2015
Drug	combo pbf-509 (160 mg) / pdr001	1	2015
Drug	combo pbf-509 (320 mg)	1	2015
Drug	combo pbf-509 (320 mg) / pdr001	1	2015
Drug	combo pbf-509 (640 mg)	1	2015
Drug	combo pbf-509 (640 mg) / pdr001	1	2015
Other	communication intervention	1	2012
Radiation	comparator: ct	1	2008
Radiation	comparator: ct/mri/fdg-pet	1	2008
Drug	comparator: erlotinib	1	2008
Drug	comparator: erlotinib / dalotuzumab	1	2008
Drug	comparator: erlotinib monotherapy	1	2008
Behavioral	comparison group)	1	2013
Drug	compound 121564	1	2018
Procedure	computed tomography-guided optical sensor-guided radiofrequency ablation	1	2005
Drug	concomitant docetaxel 20mg	1	2012
Radiation	concomitant radiotherapy	1	2017
Drug	concomitant rdt 2gy	1	2012
Other	concurrent chemo-therapy	1	2010
Radiation	concurrent chemoradiotherapy	1	2014
Drug	concurrent chemoradiotherapy (paclitaxel	1	2008
Drug	concurrent chemoradiotherapy (paclitaxel/cisplatin/radiotherapy)	1	2008
Radiation	concurrent thoracic radiation therapy	1	2006
Procedure	cone-beam computed tomography	1	2018
Radiation	conformal radiotherapy	1	2006
Radiation	conformal thoracic radiotherapy (ctrt)	1	2008
Drug	consolidation chemotherapy with docetaxel	1	2006
Drug	consolidation chemotherapy with docetaxel/cisplatin	1	2006
Drug	consolidation sintilimab	1	2019
Drug	consolidative durvalumab	1	2019
Radiation	contralateral esophageal sparing technique (cest)	1	2015
Other	control	1	2017
Other	control /	1	2017
Drug	control arm (seq):	1	2006
Radiation	conventional fractionation	1	2014
Radiation	conventional radiation	1	2011
Radiation	conventional radiotherapy	1	2016
Radiation	conventional radiotherapy (crt)	1	2013
Radiation	conventionally fractionated radiotherapy (conrt)	1	2009
Other	copd assessment test	1	2020
Other	copd assessment test/modified medical research council dyspnea patient reported outcomes	1	2020
Device	coredx pulmonary mini-forceps	1	2019
Other	counseling	1	2019
Drug	cp-675,206	1	2006
Drug	cp-751,871 / carboplatin / paclitaxel	1	2008
Drug	cpg 7909	1	2003
Drug	cpi-444	1	2017
Drug	cpl304110	1	2019
Drug	crlx101	1	2011
Drug	cross-over to osimertinib	1	2014
Procedure	cryobiopsy	1	2019
Device	cryosurgery	1	2016
Drug	cs-1008	1	2009
Drug	cs7017 tablets	1	2008
Device	ct-simulation	1	2011
Device	ct-simulation/4d pet-ct	1	2011
Other	ct for the diagnosis	1	2016
Other	ct perfusion imaging	1	2012
Diagnostic Test	ct scans	1	2018
Drug	ct053ptsa	1	2018
Other	ctdna analysis	1	2019
Diagnostic Test	ctdna blood sample	1	2019
Biological	ctl	1	2019
Drug	cudc-101	1	2010
Drug	custirsen sodium	1	2005
Drug	customized treatment	1	2008
Biological	cv301	1	2016
Biological	cv9201	1	2009
Biological	cva21	1	2016
Biological	cxcr5 modified egfr chimeric antigen receptor autologous t cells	1	2019
Radiation	cyberknife stereotactic radiosurgery	1	2008
Radiation	cyclical hypofractionated palliative radiation (quad shot)	1	2020
Drug	cyclophosphamide/fludarabine	1	2017
Genetic	cytogenetic analysis	1	2003
Drug	d	1	2012
Drug	d-0316 capsule	1	2019
Radiation	daily hyperfractionated radiation therapy	1	2017
Radiation	daily stereotactic body radiotherapy	1	2018
Drug	daratumumab	1	2016
Drug	dasatinib - 1a	1	2013
Drug	dasatinib - 1b	1	2013
Other	data feedback only	1	2012
Drug	day 8 of a 28-day cycle for 2 cycles	1	2012
Biological	dc vaccine	1	2016
Other	dce-mri scan	1	2012
Drug	debio 1143	1	2017
Behavioral	decision support tool	1	2019
Drug	decitabine (dac)	1	2017
Drug	decitabine in combination with genistein	1	2012
Drug	defactinib	1	2016
Drug	defactinib (vs-6063)	1	2013
Drug	demcizumab	1	2010
Biological	denileukin diftitox	1	2005
Drug	denosumab-nivolumab combination	1	2018
Biological	depsipeptide	1	2002
Drug	desloratadine	1	2015
Drug	detox-b adjuvant	1	2007
Device	device for pet	1	2016
Biological	dex2	1	2010
Drug	dexamethasone (or corticosteroid equivalent)	1	2008
Drug	dexamethasone (pre-	1	2007
Drug	dexamethasone (pre-/post-medication for docetaxel)	1	2007
Drug	dï¼‰	1	2019
Procedure	diagnostic thoracoscopy	1	1999
Other	dietary fasted	1	2014
Other	dietary high fat	1	2014
Behavioral	dignity therapy	1	2014
Drug	diphenhydramine	1	2019
Drug	diprosone	1	2009
Procedure	dissection of the inferior pulmonary ligament	1	2019
Drug	dkn-01	1	2011
Drug	dky709	1	2019
Drug	dmxaa in combination with carboplatin	1	2009
Drug	dmxaa in combination with carboplatin/paclitaxel	1	2009
Drug	docetaxel-carboplatin	1	2009
Drug	docetaxel (d)	1	2015
Drug	docetaxel (taxane)	1	2005
Drug	docetaxel / plinabulin (dp)	1	2015
Drug	docetaxel 20mg	1	2012
Drug	docetaxel 20mg/m2/week / carboplatin auc 2/weekly - concomitant chemoradiation 2gy/day	1	2012
Drug	docetaxel 40mg<7m2 d1,8, 21, 28	1	2012
Drug	docetaxel 40mg<7m2 d1,8, 21, 28/ gemcitabine 1200mg/m2 d1,8, 21, 28 / concomitant docetaxel 20mg/m2/w/carboplatin auc 2/w/ concomitant rdt 2gy/d	1	2012
Drug	docetaxel 60 mg	1	2012
Drug	docetaxel 60 mg/m2	1	2012
Drug	docetaxel 75 mg/m^2	1	2016
Drug	docetaxel 75 mg/m2	1	2012
Procedure	docetaxel alone	1	2010
Drug	docetaxel combination	1	2003
Drug	docetaxel h	1	2009
Drug	docetaxel m	1	2009
Drug	docetaxel, bevacizumab	1	2016
Drug	docetaxel, cisplatin	1	2005
Drug	docetaxel/bavituximab/placebo	1	2010
Drug	docetaxel/carboplatin/bevacizumab/erlotinib	1	2007
Drug	docetaxel/cddp	1	2005
Drug	docetaxel/cisplatin followed by gemcitabine	1	2007
Drug	docetaxel/gemcitabine	1	2007
Drug	docetaxel/oxaliplatin	1	2016
Drug	docetaxel/reolysin	1	2012
Drug	docetaxelâ®	1	2016
Drug	donafenib tablets	1	2019
Biological	donor-derived nk cell infusion	1	2017
Procedure	dose escalation (radiotherapy treatment schedule)	1	2005
Drug	dose escalation followed by treatment with mtd	1	2012
Biological	dostarlimab	1	2017
Genetic	dotap:chol-fus1	1	2003
Drug	dovitinib	1	2012
Drug	doxil	1	2015
Drug	doxycline	1	2007
Drug	doxycycline	1	2011
Biological	drug: hyperacute lung cancer cell vaccine	1	2003
Drug	ds-1062a	1	2018
Procedure	dual-agent therapy	1	2010
Procedure	dual-agent therapy/docetaxel alone/best supportive care	1	2010
Drug	duravalumab	1	2014
Drug	durvalumab (medi 4736)	1	2017
Combination Product	durvalumab / danvatirsen	1	2018
Biological	durvalumab /tremelimumab	1	2015
Other	durvalumab/sbrt	1	2016
Drug	dv281	1	2017
Drug	dv281 (rp2d)	1	2017
Procedure	dynamic contrast-enhanced magnetic resonance imaging	1	2008
Drug	dzd9008	1	2019
Drug	e7080	1	2009
Drug	e7389 21 day cycle	1	2005
Drug	e7389 28 day cycle	1	2005
Dietary Supplement	eaa	1	2010
Dietary Supplement	eaa/leu vs total aa	1	2010
Procedure	ebus-tbna, eus-na	1	2017
Drug	ec145	1	2012
Drug	ec145 / docetaxel	1	2012
Drug	ec1456	1	2013
Drug	ec1456/ec20	1	2013
Drug	efaproxiral	1	2000
Drug	eftilagimod alpha	1	2018
Biological	egf-pti	1	2018
Drug	egfr-tk inhibitor	1	2018
Drug	egfr-tki	1	2015
Genetic	egfr mutation test	1	2009
Drug	egfr/egfrviii inhibitor wsd0922-fu	1	2019
Drug	egfrviii inhibitor wsd0922-fu	1	2019
Drug	ekb-569	1	2003
Drug	eloxatin (gemox)	1	2004
Drug	emb-01	1	2018
Drug	emd 273066	1	2005
Biological	emd 521873	1	2009
Drug	emibetuzumab	1	2013
Drug	encorafenib	1	2019
Procedure	endobronchial ultrasound-guided transbronchial needle aspiration (ebus-tbna)	1	2016
Procedure	endobronchial ultrasound (ebus)	1	2010
Procedure	endobronchial ultrasound (ebus) transbronchial needle aspirate (tbna)	1	2017
Procedure	endobronchial ultrasound guided transthoracic needle biopsy	1	2006
Procedure	endoscopic ultrasound staging	1	2007
Drug	endostar -continued pumping into	1	2012
Drug	endostar -continued pumping into/gp	1	2012
Drug	endostar -injecting into	1	2012
Drug	endostar -injecting into /gp	1	2012
Drug	endostar(recombinant human endostatin injection)	1	2008
Drug	endostatin	1	2015
Dietary Supplement	energy goal-based ons	1	2018
Behavioral	enhanced care (intervention group	1	2013
Behavioral	enhanced care (intervention group/comparison group)	1	2013
Biological	enoblituzumab/ipilimumab	1	2015
Drug	enoxaparin	1	2008
Drug	ensartinib with fed	1	2018
Drug	ensartinib with fed/fasting	1	2018
Biological	enumeration of endothelial cell progenitor in peripheral blood by flow cytometry, endothelial cell progenitor characterization by primary cell cultures	1	2009
Drug	enzalutamide	1	2016
Drug	enzastaurin hcl	1	2005
Drug	enzyme inhibitor therapy	1	2017
Behavioral	eortc qlq-c30 questionnaire	1	2020
Biological	ep2101	1	2003
Drug	epacadostat 100 mg	1	2016
Drug	epacadostat 25 mg	1	2016
Drug	epacadostat 300 mg	1	2016
Drug	epirubicin	1	2005
Biological	epoetin alfa	1	2002
Drug	epothilone	1	2002
Drug	epothilone d	1	2004
Behavioral	eq-5d	1	2015
Drug	erbitux	1	2010
Drug	erdafitinib	1	2016
Drug	eribulin	1	2011
Drug	eribulin in combination	1	2013
Drug	eribulin mesylate / erlotinib	1	2010
Drug	erlotinib (tarceva)/bexarotene (targretin)	1	2005
Drug	erlotinib / docetaxel	1	2011
Drug	erlotinib / placebo	1	2007
Drug	erlotinib / sorafenib	1	2007
Drug	erlotinib 150	1	2014
Drug	erlotinib 150/100 mg	1	2014
Drug	erlotinib in combination with capecitabine	1	2009
Drug	erlotinib in combination with dasatinib	1	2007
Drug	erlotinib, bevacizumab	1	2010
Drug	erlotinib, sunitinib	1	2007
Drug	erlotinib/bevacizumab	1	2017
Drug	erlotinib/bexarotene	1	2005
Drug	erlotinib/placebo	1	2008
Drug	erythromycin [eritex]	1	2008
Procedure	escalation of dose (radiotherapy treatment)	1	2005
Radiation	esophageal-sparing intensity-modulated radiotherapy	1	2016
Radiation	esophageal sparing imrt	1	2009
Drug	ethaselen	1	2014
Device	ethicon powered vascular stapler	1	2016
Drug	etirinotecan pegol (nktr-102)	1	2013
Drug	etoposide (50mg	1	2012
Drug	etoposide (50mg/m2) iv (in the vein) on day 1 to day 5 of a 28-day cycle for 2 cycles	1	2012
Drug	etoposide (dose level 1)	1	2018
Drug	etoposide (dose level 2)	1	2018
Drug	etoposide 100 mg	1	2013
Drug	etoposide 100 mg/m^2	1	2013
Drug	eu-approved avastinâ®	1	2017
Behavioral	european organization for research	1	2015
Behavioral	european organization for research/treatment of cancer quality of life questionnaire c30	1	2015
Behavioral	european organization for research/treatment of cancer quality of life questionnaire lc-13	1	2015
Other	evaluation of response by recist	1	2017
Other	evozac calming skin spray	1	2012
Drug	ex vivo-expanded her2-specific t cells	1	2005
Drug	exatecan mesylate	1	2000
Device	exatherm-tbh system	1	2015
Other	exercise /	1	2017
Behavioral	exercise intervention	1	2013
Other	exhaled breath collection	1	2019
Drug	experimental arm (con):	1	2006
Other	experimental intervention	1	2016
Drug	experimental: rp2d (pbf-509	1	2015
Drug	experimental: rp2d (pbf-509/pdr001)_immuno treated	1	2015
Radiation	external beam radiation (dose level 1)	1	2018
Radiation	external beam radiation (dose level 2)	1	2018
Radiation	external beam radiation (hyperfractionated)	1	2018
Radiation	external beam radiation (standard)	1	2018
Drug	famitinib h	1	2015
Drug	famitinib h / docetaxel	1	2015
Drug	famitinib l	1	2015
Drug	famitinib l / docetaxel	1	2015
Drug	famitinib m	1	2015
Drug	famitinib m / docetaxel	1	2015
Drug	fasting	1	2018
Other	fasting-mimicking diet	1	2018
Drug	fate-nk100	1	2017
Procedure	fatigue assessment	1	1999
Procedure	fatigue assessment/management	1	1999
Device	faza pet scan	1	2015
Drug	fdg	1	2009
Other	feces samples	1	2018
Drug	fexofenadine tablet dosing	1	2016
Device	fiber optic	1	2016
Biological	filgrastim	1	1999
Drug	filgrastim-sd	1	2002
Drug	filgrastim-sd/01	1	2002
Drug	first-line chemotherapy agents	1	2006
Drug	fisiogel	1	2008
Other	fitbit	1	2018
Drug	fkb238 (bevacizumab)	1	2016
Drug	flt	1	2009
Drug	flt3 ligand therapy (cdx-301)	1	2016
Genetic	fluorescence in situ hybridization	1	2007
Drug	fluorine f 18 ara-g	1	2019
Radiation	fluorine f 18 ef5	1	2009
Other	fluorine f 18 fluorothymidine	1	2007
Drug	fluoro-d-glucose	1	2010
Drug	fluoro-l-thymidine	1	2010
Drug	fluorouracil	1	2006
Drug	fluoxetine	1	2000
Drug	folate	1	2005
Drug	folfox (oxaliplatin	1	2013
Drug	folfox (oxaliplatin/leucovorin/5-fluorouracil)	1	2013
Drug	follow-up for 1 year;	1	2020
Procedure	forceps biopsy	1	2019
Drug	fosbretabulin	1	2008
Drug	fostamatinib disodium	1	2009
Procedure	four dimensional computed tomographic imaging (4dct)	1	2016
Radiation	fr. x 3 fractions	1	2013
Drug	fr901228	1	2007
Radiation	fraction	1	2018
Radiation	free breathing	1	2006
Biological	fresolimumab	1	2015
Combination Product	fsrt	1	2020
Combination Product	fsrt/with bevacizumab	1	2020
Drug	fulvestrant	1	2005
Procedure	functional imaging of treatment effects	1	2005
Radiation	functionally adapted, dose escalated vmat radiotherapy	1	2018
Drug	fusidic acid [verutex]	1	2008
Drug	g-csf (pegfilgrastim) 3.6 mg	1	2013
Drug	g1t38	1	2018
Drug	gadolinium-dpta	1	2010
Drug	galunisertib	1	2015
Drug	gamma-secretase inhibitor ro4929097	1	2010
Drug	ganetespib	1	2012
Biological	gb222	1	2019
Drug	gb226	1	2019
Drug	gdc-0994	1	2015
placebo	gefitinib-matching placebo 250 mg	1	2020
Drug	gefitinib 250mg	1	2009
Drug	gefitinib 500mg	1	2009
Drug	gefitinib 500mg/gefitinib 250mg	1	2009
Drug	gefitinib retreatment	1	2009
Drug	gefitinib, pemetrexed,cisplatin	1	2017
Drug	gefitinib/bkm120	1	2012
Drug	gefitinib/docetaxel	1	2005
Drug	gefitinib/metformin	1	2013
Drug	gefitinib/nimotuzumab	1	2011
Drug	gefitinib/olaparib	1	2011
Drug	gefitinib/placebo	1	2013
Drug	gemcitabine / cisplatine	1	2005
Drug	gemcitabine /carboplatin	1	2011
Drug	gemcitabine 1200mg	1	2012
Drug	gemcitabine cisplatin followed by docetaxel	1	2007
Drug	gemcitabine hcl	1	2006
Drug	gemcitabine injection	1	2012
Drug	gemcitabine platinum	1	2014
Drug	gemcitabine platinum/with erlotinib	1	2014
Drug	gemcitabine prolonged continuous infusion	1	2006
Drug	gemcitabine, carboplatin	1	2005
Drug	gemcitabine, carboplatin, bevacizumab	1	2006
Drug	gemcitabine, cisplatin	1	2005
Drug	gemcitabine/cisplatin/gemcitabine/carboplatin	1	2008
Drug	gemcitabine/eloxatin (gemox)	1	2004
Drug	gemcitabine/nab-paclitaxel	1	2013
Drug	gemcitabine/pemetrexed, paclitaxel/gemcitabine	1	2007
Drug	gemcitabine/with cisplatin	1	2013
Drug	gemcitabineâ®	1	2016
Genetic	genetic linkage analysis	1	2012
Drug	genexol-pm	1	2013
Drug	genexol-pm/gemcitabine	1	2013
Biological	gi-4000	1	2008
Drug	gilotrif	1	2013
Drug	glesatinib	1	2016
Drug	glufosfamide	1	2000
Drug	gold sodium thiomalate	1	2007
Drug	gp	1	2012
Drug	gr-md-02	1	2015
Drug	grapiprant	1	2018
Drug	grapiprant/pembrolizumab	1	2018
Radiation	group 1: peripherally located tumors	1	2016
Radiation	group 2: peripherally located chest wall adjacent tumors	1	2016
Radiation	group 3: centrally located tumors	1	2016
Biological	gsk 249553 vaccine	1	2006
Drug	gsk1120212	1	2011
Drug	gt103	1	2020
Biological	gti-2040	1	2003
Diagnostic Test	guardant360	1	2018
Biological	gv 1001 telomerase peptide	1	2007
Drug	hbi-8000 in combination with nivolumab	1	2016
Drug	hd204	1	2017
Drug	hdm201	1	2016
Drug	hdregn2810	1	2018
Biological	hekt cell	1	2017
Drug	hemay020	1	2015
Radiation	heterogeneously hypofractionated radiotherapy	1	2017
Drug	hh2710	1	2019
Biological	high-activity natural killer	1	2016
Radiation	high dose chemoradiotherapy	1	2018
Radiation	high dose radiotherapy	1	2005
Other	high performance liquid chromatography	1	2008
Radiation	hippocampal-sparing wbrt	1	2015
Drug	hki-272	1	2005
Biological	hla-a*0201	1	2010
Biological	hla-a0201/hla-a0206-restricted urlc10 peptides	1	2010
Biological	hla-a*0201restricted urlc10 peptides with adjuvant	1	2013
Biological	hla-a*0206-restricted urlc10 peptides	1	2010
Biological	hla-a*2402restricted urlc10, cdca1, vegfr1	1	2009
Biological	hla-a*2402restricted urlc10, cdca1, vegfr1/vegfr2	1	2009
Biological	hla-a*2402restricted urlc10, cdca1,/kif20a peptides	1	2010
Biological	hla-a*2402restricted urlc10, cdca1,/kif20a peptides with adjuvant	1	2013
Biological	hla-a*2402restricted urlc10, ttk, vegfr1	1	2008
Biological	hla-a*2402restricted urlc10, ttk, vegfr1/vegfr2	1	2008
Drug	hlx04, a bevacizumab biosimilar	1	2019
Drug	hlx10	1	2019
Drug	hlx10, an engineered anti-pd-1 antibody	1	2019
Drug	hmab biwa 4	1	2014
Drug	hpph	1	2012
Biological	hpv vaccine	1	2013
Drug	hs-10296	1	2018
Biological	hsppc-96	1	2004
Drug	hycamtin, oral capsules	1	2006
Radiation	hypofractionated radiation	1	2016
Radiation	hypofractionated radiation/chemotherapy	1	2016
Radiation	hypofractionated radiotherapy (hyport)	1	2009
Drug	i124-nm404	1	2007
Drug	ibi305	1	2019
Drug	icotinib hydrochloride tablets	1	2019
Drug	idasanutlin	1	2017
Biological	idc-g305	1	2013
Drug	idelalisib	1	2017
Drug	ifosfamide, gemcitabine	1	2008
Dietary Supplement	igen0206	1	2019
Biological	ilixadencel	1	2018
Device	illinois bone marrow aspiration neddle	1	2015
Drug	ilx651	1	2004
Biological	ima201 product	1	2017
Drug	ima202 product	1	2018
Radiation	image-guided adaptive radiation therapy	1	2012
Other	imaging biomarker analysis	1	2007
Behavioral	imaging studies)	1	2013
Biological	imc-1121b (ramucirumab)	1	2010
Biological	imc-a12 (cixutumumab)	1	2009
Drug	imetelstat	1	2010
Drug	imetelstat sodium (grn163l)	1	2007
Drug	imexon	1	2006
Drug	imiquimod	1	2013
Drug	immu-132	1	2012
Drug	immune checkpoint inhibitors	1	2016
Drug	immune checkpoint inhibitors/docetaxel	1	2016
Biological	immune killer cells (ikc)	1	2018
Drug	immuno-therapeutic agent	1	2017
Other	immunologic technique	1	2008
Biological	immunotherapy	1	2016
Biological	immunotherapy (standard of care)	1	2017
Drug	imo-2055	1	2008
Radiation	imp-288-indium	1	2010
Radiation	imp-288-lutetium	1	2010
Drug	imprime pgg	1	2016
Biological	imprime pgg injection	1	2009
Biological	imprime pggâ® injection	1	2009
Drug	inbrx-106 - hexavalent ox40 agonist antibody	1	2019
Drug	inc280 (capmatinib)	1	2015
Drug	individualized neoantigen peptides vaccine	1	2020
Drug	individualized pharmacokinetically driven paclitaxel dosing	1	2011
Drug	indoximod	1	2015
Drug	induction chemotherapy	1	2013
Biological	infliximab	1	2002
Drug	inhalation of hyperpolarized xenon gas	1	2014
Drug	iniparib	1	2010
Other	injection of [18f]-ods2004436 radiotracer	1	2016
Procedure	injection of 99m-tc-nm-01	1	2016
Other	integrated palliative care intervention	1	2009
Radiation	intensity-modulated radiation therapy (imrt)	1	2017
Radiation	intensity modulated radiation therapy (imrt)	1	2019
Radiation	intensity modulated radiotherapy treatment	1	2013
Procedure	intercostal uniportal vats	1	2017
Drug	interleukin-2 (il2)	1	2017
Other	internet-based intervention	1	2011
Other	intervention arm	1	2013
Drug	intralesional il-2	1	2017
Drug	intravenous (iv) sea-cd40	1	2015
Procedure	intubated anesthesia with single-lung mechanical ventilation	1	2018
Drug	investigational drug	1	2002
Drug	investigatorâ´s choice of chemotherapy	1	2010
Diagnostic Test	invision	1	2019
Drug	ipatasertib	1	2017
Drug	ipi-504	1	2011
Drug	ipi-549	1	2015
Drug	ipi 504	1	2011
Drug	ipi 504/docetaxel	1	2011
Biological	ipilimumab 1 mg	1	2013
Biological	ipilimumab 1 mg/kg	1	2013
Drug	ipilimumab, 10 mg	1	2010
Drug	ipilimumab, 3 mg	1	2010
Drug	ipilimumab/radiation therapy	1	2017
Drug	irx4204	1	2016
Drug	isatuximab sar650984	1	2017
Drug	iscar quercus	1	2006
Drug	isis eif4e rx	1	2010
Drug	isoquercetin	1	2014
Radiation	isotoxic hypofractionated group	1	2018
Radiation	isotoxic hypofractionation	1	2018
Drug	isovue-200	1	2016
Drug	ispinesib	1	2004
Drug	itraconazole 200 mg	1	2018
Radiation	itv	1	2012
Drug	ixabepilone, 32 mg/m^2	1	2008
Drug	ixabepilone, 32 mg/m^2 / carboplatin, 5 mg/min/ml	1	2008
Drug	ixabepilone, 32 mg/m^2 / carboplatin, 6 mg/min/ml	1	2008
Drug	jin fu kang	1	2005
Drug	jnj-74699157	1	2019
Drug	kanglaite injection	1	2019
Drug	kanglaite injection/chemotherapy	1	2019
Drug	karenitecin	1	2001
Drug	karenitecin (bnp1350)	1	2004
Drug	keytruda injectable product	1	2019
Genetic	ki-67 protein expression	1	2009
Biological	kif20a peptides	1	2010
Biological	kif20a peptides with adjuvant	1	2013
Drug	kos-1584	1	2008
Drug	l-nmma	1	2017
Drug	ladiratuzumab vedotin	1	2019
Procedure	laser ablation	1	2018
placebo	lazertinib-matching placebo 240 mg	1	2020
Drug	lazertinib-matching placebo 240 mg/160 mg	1	2020
Drug	lazertinib 240 mg	1	2020
Drug	lazertinib 240 mg/160 mg	1	2020
Drug	lbh589	1	2007
Drug	lcl161	1	2016
Drug	ldk378(ceritinib)	1	2017
placebo	lenvatinib matched placebo	1	2012
Other	less frequent surveillance strategy	1	2015
Dietary Supplement	leu	1	2010
Dietary Supplement	leu vs total aa	1	2010
Drug	leucovorin	1	2013
Drug	leucovorin calcium	1	2006
Behavioral	lifestyle counseling	1	2014
Behavioral	light physical activity 1	1	2018
Behavioral	light physical activity 2	1	2018
Drug	linagliptin	1	2017
Dietary Supplement	lindera obtusiloba extract	1	2020
Drug	linifanib	1	2010
Combination Product	litt	1	2019
Combination Product	litt / pembrolizumab	1	2019
Drug	lmb-100	1	2019
Radiation	local definitive radiotherapy	1	2017
Radiation	local radiation therapy	1	2019
Drug	lomustine	1	2006
Drug	loperamide	1	2013
Genetic	loss of heterozygosity analysis	1	2003
Radiation	low-let cobalt-60 gamma ray therapy	1	1999
Drug	loxo-292 (selpercatinib)	1	2017
Diagnostic Test	lsi alk break apart dna fish test	1	2019
Drug	ltt462	1	2016
Biological	lucanixâ„¢	1	2008
Procedure	lung surgery	1	2015
Drug	lurbinectedin (pm01183)	1	2013
Drug	ly01008	1	2018
Drug	ly2181308	1	2010
Drug	ly293111	1	2003
Drug	ly3023414	1	2014
Drug	ly573636-sodium	1	2006
Drug	lyc-55716	1	2018
Procedure	lymphadenectomy	1	2008
Drug	m2 d1,8, 21, 28	1	2012
Drug	m2) iv (in the vein) on day 1	1	2012
Drug	m2) iv (in the vein) on day 1 to day 5 of a 28-day cycle for 2 cycles	1	2012
Drug	m200 (volociximab), carboplatin, paclitaxel	1	2008
Drug	m200 (volociximab), carboplatin, paclitaxel, bevacizumab	1	2008
Drug	m2es	1	2010
Drug	mac-321	1	2003
Drug	maintenance chemotherapy	1	2014
Procedure	management	1	1999
Biological	mapatumumab	1	2007
Drug	marimastat	1	1999
Other	mass spectrometry	1	2007
placebo	matching placebo	1	2020
Drug	matuzumab	1	2005
Drug	mb02 (bevacizumab biosimilar drug)	1	2017
Biological	mdx-1106	1	2007
Drug	medi-575	1	2010
Drug	medi4736 (anti-pd-l1)	1	2015
Biological	medi4736 (durvalumab)	1	2015
Biological	medi4736 (durvalumab)/tremelimumab	1	2015
Drug	medi5752	1	2018
Drug	medi7247	1	2018
Biological	medi9447	1	2017
Procedure	mediastinoscopy	1	2010
Other	medical history data collection	1	2019
Behavioral	medical outcomes study social support survey	1	2015
Drug	megf0444a	1	2011
Drug	mek162	1	2013
Drug	merestinib	1	2016
Diagnostic Test	mesothelin expression	1	2019
Other	met analysis on tissue	1	2012
Other	met analysis on tissue/blood	1	2012
Drug	methotrexate	1	2018
Drug	methoxy polyethylene glycol-epoetin beta [mircera]	1	2006
Drug	metmab	1	2009
Drug	metronidazole actavis	1	2008
Biological	mg1-magea3	1	2016
Biological	mga012	1	2015
Biological	mga271	1	2011
Drug	mgcd265	1	2015
Genetic	microarray analysis	1	2003
Procedure	microwave ablation	1	2018
Radiation	mid-position radiation strategy	1	2012
Drug	mifepristone/eribulin in combination	1	2013
Drug	mil60	1	2017
Biological	milsâ„¢ - nsclc	1	2019
Device	miso pet scan	1	2015
Drug	mistletoe extract	1	2007
Other	mitochondria-targeted system therapy	1	2019
Other	mitochondria-targeted system therapy/with radiofrequency ablation	1	2019
Drug	mitomycin	1	2005
Drug	mitomycin c	1	1999
Drug	mk-1308	1	2018
Drug	mk-3475 (phase i)	1	2015
Drug	mk-3475 (phase ii)	1	2015
Biological	mk-4280	1	2018
Biological	mk-4830	1	2019
Biological	mk-5890	1	2019
Biological	mk-7684	1	2019
Drug	mkc-1	1	2006
Drug	mocetinostat	1	2016
Drug	modafinil	1	2009
Behavioral	modified medical research council	1	2015
Other	modified medical research council dyspnea patient reported outcomes	1	2020
Biological	modified vaccinia virus ankara vaccine expressing p53	1	2015
Device	modulated electro-hyperthermia (meht)	1	2016
Biological	mogamulizumab	1	2015
Procedure	molecular profiling	1	2011
Drug	monalizumab (iph2201	1	2019
Biological	monoclonal antibody 11d10 anti-idiotype vaccine	1	2000
Biological	monoclonal antibody 3h1 anti-idiotype vaccine	1	2000
Drug	monotherapy (gemcitabine	1	2006
Drug	monotherapy (gemcitabine/vinorelbine)	1	2006
Biological	montanide isa 51 vaccine	1	2016
Drug	morab-009	1	2006
Other	more frequent surveillance strategy	1	2015
Drug	motesanib diphosphate	1	2004
Drug	motexafin gadolinium injection	1	2005
Device	move for surgery preconditioning program using a wearable activity tracker (fitbit) intervention group	1	2018
Radiation	mri	1	2008
Drug	mtig7192a	1	2018
Radiation	multiple-fraction stereotactic body radiation therapy (sbrt)	1	2009
Biological	mutant p53 peptide pulsed dendritic cell vaccine	1	2001
Biological	mva-muc1-il2	1	2006
Biological	mycobacterium w.	1	2008
Drug	n-803	1	2018
Drug	n-803 / pembrolizumab	1	2018
Drug	nab-paclitaxel 100 mg	1	2013
Drug	nab-paclitaxel 100 mg/m^2	1	2013
Drug	nab-paclitaxel iv	1	2014
Drug	nab-paclitaxel/carboplatin	1	2018
Drug	nadaplatin	1	2015
Drug	nadaplatin/pemetrexed	1	2015
Drug	nafulizumab	1	2020
Drug	naloxegol	1	2017
Drug	naquotinib	1	2014
Biological	natural killer	1	2017
Biological	natural killer t cell	1	2017
Biological	natural killer/natural killer t cell	1	2017
Procedure	nausea	1	1999
Procedure	nausea/vomiting therapy	1	1999
Drug	navarixin	1	2018
Drug	navelbine	1	2005
Drug	navitoclax	1	2015
Drug	nb-paclitaxel	1	2019
Drug	nc318	1	2018
Drug	nelfinavir mesylate	1	2007
Drug	neoadjuvant chemotherapy (taxol	1	2009
Drug	neoadjuvant chemotherapy (taxol/carboplatin)	1	2009
Drug	neoadjuvant erlotinib therapy	1	2008
Drug	neoadjuvant gemcitabine	1	2008
Drug	neoadjuvant gemcitabine/carboplatin therapy	1	2008
Radiation	neoadjuvant stereotactic body radiation (sbrt)	1	2015
Drug	neratinib	1	2013
Drug	neulastaâ® (pegfilgrastim)	1	2005
Drug	nexavar (sorafenib, bay43-9006)	1	2010
Drug	ngr-htnf	1	2009
Drug	nicotinamide	1	2015
Drug	nicotine replacement therapy	1	2011
Drug	nintedanib (bibf1120)	1	2008
Drug	nivolumab / ipilimumab	1	2017
Drug	nivolumab / plinabulin	1	2016
Drug	nivolumab 360 mg	1	2017
Drug	nivolumab, ipilimumab	1	2017
Drug	nivolumab, pembrolizumab	1	2018
Combination Product	nk cell	1	2019
Combination Product	nk cell/pd-1 antibody	1	2019
Biological	nk cells	1	2008
Drug	nktr-214	1	2017
Diagnostic Test	no daily chest xray	1	2018
Drug	no local definitive radiotherapy	1	2017
Other	no metformin	1	2019
Radiation	no personalized dose redistribution	1	2015
Other	non-active moisturizing cream	1	2008
Radiation	non-daily stereotactic body radiotherapy	1	2018
Other	non-investigational platinum-based doublet chemotherapy	1	2015
Radiation	non-surgical lat	1	2019
Other	none, standard chemotherapy only	1	2014
Drug	nov-002 injection in combination with carboplatin vs. paclitaxel	1	2006
Drug	nov-002 injection in combination with carboplatin vs. paclitaxel/carboplatin	1	2006
Device	novottf-100m device	1	2016
Drug	npi-0052 (marizomib)	1	2008
Drug	npi-0052 (marizomib) / vorinostat	1	2008
Drug	npi-2358	1	2008
Drug	npi-2358 / docetaxel	1	2008
Drug	ocz103-os	1	2013
Drug	od for 12 weeks	1	2007
Drug	ogx-427	1	2013
Biological	olaratumab	1	2009
Drug	oleclumab (medi9447)	1	2019
Drug	olmutinib	1	2017
Drug	omaveloxolone	1	2013
Drug	ombrabulin (ave8062)	1	2010
Drug	onalespib lactate	1	2015
Drug	onartuzumab (metmab)	1	2011
Drug	onartuzumab [metmab]	1	2014
Diagnostic Test	oncomine	1	2019
Dietary Supplement	oncoxinâ®	1	2018
Dietary Supplement	ons from the start of radiotherapy	1	2018
Dietary Supplement	ons from the time of grade 2 radiation esophagitis	1	2018
Drug	opdivo	1	2017
Procedure	or of all oligometastases	1	2019
Drug	oral decitabine	1	2016
Drug	oral taxane	1	2005
Drug	oral vinorelbine/cisplatin with concomitant radiotherapy 66 gy (total dose)	1	2008
Drug	ose2101	1	2016
Drug	osi-774 (tarceva)	1	2005
Drug	osi-774: erlotinib, tarcevatm	1	2007
Drug	osimertinib 80 mg [tagrisso]	1	2017
Drug	osimertinib 80mg	1	2018
Drug	osimertinib 80mg/40mg	1	2018
Drug	osimertininb tablet dosing	1	2016
Drug	oxaliplatin, gemcitabine, bevacizumab	1	2005
Drug	oxaliplatine	1	2005
Drug	oxaliplatine / gemcitabine / vinorelbine	1	2005
Drug	pabolizumab	1	2020
Drug	paclitaxel-carboplatin	1	2008
Drug	paclitaxel (cp)	1	2004
Drug	paclitaxel (genexolâ®)	1	2009
Drug	paclitaxel (taxane)	1	2005
Drug	paclitaxel (taxol)	1	2008
Drug	paclitaxel / carboplatine	1	2005
Drug	paclitaxel 200mg	1	2017
Drug	paclitaxel 200mg/m2	1	2017
Drug	paclitaxel 45 mg	1	2018
Drug	paclitaxel 45 mg/m^2	1	2018
Drug	paclitaxel dosing according to smpc	1	2011
Drug	paclitaxel liposome	1	2016
Drug	paclitaxel loaded polymeric micelle (genexol-pmâ®)	1	2009
Drug	paclitaxel micelles for injection	1	2016
Drug	paclitaxel poliglumex, pemetrexed	1	2007
Drug	paclitaxel, 200 mg	1	2008
Drug	paclitaxel, 200 mg/m^2	1	2008
Drug	paclitaxel, carboplatin	1	2008
Drug	paclitaxel, carboplatin/bevacizumab,erlotinib	1	2008
Drug	paclitaxel, cisplatin, carboplatin	1	2013
Drug	paclitaxel, vinorelbine, cisplatin	1	2005
Drug	paclitaxel/carboplatin/gefitinib	1	2010
Drug	paclitaxel/cisplatin	1	2008
Drug	paclitaxel/docetaxel/carboplatin/cisplatin	1	2013
Procedure	pain therapy	1	1999
Drug	palifermin	1	2004
Other	palliative radiotherapy	1	2009
Other	palliative radiotherapy/chemotherapy	1	2009
Other	palliative therapy	1	2014
Procedure	palliative thoracic radiotherapy	1	2005
Drug	panobinostat	1	2016
Drug	panobinostat (lbh589), sorafenib	1	2009
Drug	panobinostat, cisplatin, pemetrexed	1	2011
Drug	papaverine hydrochloride	1	2019
Drug	para-toluenesulfonamide	1	2018
Procedure	parametric imaging	1	2016
Drug	part a - azd9291 in combination with azd6094	1	2014
Drug	part a - azd9291 in combination with continuous selumetinib (asian subjects)	1	2014
Drug	part a - azd9291 in combination with continuous selumetinib (non-asian subjects)	1	2014
Drug	part a - azd9291 in combination with intermittent selumetinib	1	2014
Drug	part a - azd9291 in combination with medi4736	1	2014
Drug	part a: azd8186 monotherapy	1	2013
Drug	part b - azd9291 in combination with azd6094	1	2014
Drug	part b - azd9291 in combination with medi4736	1	2014
Drug	part b - azd9291 in combination with selumetinib	1	2014
Drug	part b: azd8186 monotherapy	1	2013
Drug	part c - azd6094 monotherapy (japan only)	1	2014
Drug	part c - azd9291 in combination with azd6094 (japan only)	1	2014
Drug	part c1: abiraterone acetate combination with azd8186	1	2013
Drug	part c2: abiraterone acetate combination with azd8186	1	2013
Drug	part d - azd9291 in combination with azd6094	1	2014
Drug	part d1: azd2014 combination with azd8186	1	2013
Drug	part d2 azd2014 combination with azd8186	1	2013
Behavioral	patient navigation	1	2016
Drug	pazopanib (gw786034)	1	2008
Drug	pazopanib/pemetrexed	1	2009
Drug	pbf-1129	1	2017
Drug	pbf-509_160 mg	1	2015
Drug	pbf-509_320 mg	1	2015
Drug	pbf-509_640 mg	1	2015
Drug	pbf-509_80 mg	1	2015
Drug	pd-0325901	1	2013
Combination Product	pd-1 antibody	1	2019
Biological	pd-1 knockout	1	2018
Other	pd-1 knockout t cells	1	2016
Drug	pd-1 mab	1	2018
Other	pd-l1 positive vs pd-l1 negative nsclc patients	1	2018
Drug	pd0332991	1	2011
Biological	pdc*lung01	1	2019
Drug	pdr001)_immuno naã¯ve	1	2015
Drug	pdr001)_immuno treated	1	2015
Other	pe	1	2011
Drug	pegilodecakin	1	2013
Drug	pegylated g-csf	1	2013
Drug	pegylated irinotecan	1	2014
Drug	pegylated recombinant human endostatinï¼ˆpeg-endoï¼‰	1	2020
Biological	pembrolizumab (keytrudaâ®)	1	2019
Biological	pembrolizumab 10 mg	1	2013
Biological	pembrolizumab 10 mg/kg	1	2013
Drug	pembrolizumab 100 mg i.v single dose	1	2016
Drug	pembrolizumab 200 mg iv single dose	1	2016
Drug	pembrolizumab 200 mg iv twice interval 21 days	1	2016
Drug	pembrolizumab 200 mg iv twice interval 21d,surgery after 10d	1	2016
Drug	pembrolizumab/bevacizumab	1	2016
Drug	pembrolizumab/chemotherapy	1	2018
Drug	pembrort	1	2018
Drug	pemetrexed - after protocol amendment	1	2006
Drug	pemetrexed - before protocol amendment	1	2006
Drug	pemetrexed (alimta) in combination with gemcitabine (gemzar)	1	2002
Drug	pemetrexed 1000 mg	1	2005
Drug	pemetrexed 1000 mg/m2	1	2005
Drug	pemetrexed 500 mg/m2	1	2005
Drug	pemetrexed disodium f injection	1	2020
Drug	pemetrexed phase 1	1	2007
Drug	pemetrexed phase 2	1	2007
Drug	pemetrexed regimen)	1	2016
Drug	pemetrexed, docetaxel	1	2011
Drug	pemetrexed, docetaxel/gemcitabine	1	2011
Drug	pemetrexed, paclitaxel	1	2007
Drug	pemetrexed/ carboplatin	1	2018
Drug	pemetrexed/ cisplatin	1	2018
Drug	pemetrexed/cisplatin intercalating gefitinib	1	2017
Biological	pemetrexed/donor-derived nk cell infusion	1	2017
Drug	pemetrexed/gemcitabine/bevacizumab	1	2007
Drug	pemetrexed/reolysin (and safety run-in)	1	2012
Drug	pemetrexedâ®	1	2016
Drug	pentoxifylline	1	2013
Drug	perifosine	1	2006
Radiation	peripherally located lung tumor	1	2009
Radiation	personalized dose redistribution	1	2015
Behavioral	personalized exercise program	1	2017
Drug	pertuzumab / trastuzumab / docetaxel	1	2019
Combination Product	pet-based, dose-painted, accelerated chemoradiotherapy	1	2018
Diagnostic Test	pet-mri	1	2018
Procedure	pet diagnostic imaging	1	2005
Procedure	pet imaging	1	2005
Diagnostic Test	pet scan	1	2018
Procedure	pet scan use in radiotherapy planning	1	2000
Diagnostic Test	pet/ct scans	1	2018
Drug	pevonedistat	1	2019
Drug	pf-05082566	1	2011
Drug	pf-06747775	1	2015
Drug	pf-06804103	1	2017
Biological	pf-06936308	1	2018
Drug	pf-3512676 / erlotinib	1	2006
Procedure	pharmacokinetic sampling	1	2014
Procedure	pharmacokinetic sampling - rifampicin	1	2014
Procedure	pharmacokinetic sampling - rosuvastatin	1	2014
Procedure	pharmacokinetic sampling - simvastatin	1	2014
Radiation	photons	1	2014
Procedure	physical therapy	1	2019
Procedure	physician does not receive the results	1	2011
Procedure	physician receives qol results	1	2011
Other	physiological saline	1	2012
Drug	pi3k inhibitor bkm120	1	2012
Drug	pictilisib	1	2011
Drug	pilimumab	1	2015
Drug	pirotinib	1	2018
Drug	pivanex	1	2003
placebo	placebo (0.9 % saline)	1	2009
placebo	placebo (for bavituximab)	1	2013
placebo	placebo (for ramucirumab)	1	2010
placebo	placebo ast2818 80mg	1	2018
Drug	placebo ast2818 80mg//40 mg	1	2018
Drug	placebo azd9291 80 mg/ 40 mg	1	2014
Drug	placebo azd9291 80 mg/40 mg	1	2015
placebo	placebo erlotinib	1	2011
placebo	placebo erlotinib 150	1	2014
Drug	placebo erlotinib 150/100mg	1	2014
placebo	placebo for abt-869	1	2008
placebo	placebo for ipilimumab	1	2017
placebo	placebo for lenvatinib	1	2019
placebo	placebo for veliparib	1	2014
placebo	placebo granules	1	2016
placebo	placebo matching lenvatinib	1	2019
placebo	placebo of aprepitant	1	2015
placebo	placebo of desloratadine	1	2015
placebo	placebo osimertinib 80mg	1	2018
Drug	placebo osimertinib 80mg/40mg	1	2018
placebo	placebo pf00299804	1	2011
placebo	placebo tablet	1	2019
placebo	placebo tablets	1	2008
placebo	placebo to bibf 1120 es	1	2014
placebo	placebo to denosumab	1	2013
placebo	placebo to match zd6474, vandetanib	1	2008
placebo	placebo to zoledronic acid	1	2013
Drug	placebo/chemotherapy	1	2018
placebo	placebo1	1	2019
placebo	placebo2	1	2019
Drug	platinum-based agent	1	2007
Drug	platinum-based doublet chemotherapy	1	2009
Drug	platinum-based two drug chemotherapy (cisplatin	1	2016
Drug	platinum-based two drug chemotherapy (cisplatin/carboplatin / vinorelbine/cisplatin/carboplatin / pemetrexed regimen)	1	2016
Drug	platinum / gemcitabine	1	2005
Drug	platinum based chemotherapy	1	2018
Drug	platinum chemotherapy (cisplatin	1	2009
Drug	platinum chemotherapy (cisplatin/carboplatin)	1	2009
Drug	plb1003	1	2017
Drug	plinabulin	1	2016
Drug	plinabulin (dp)	1	2015
Biological	polyiclc	1	2012
Genetic	polymorphism analysis	1	2012
Drug	ponatinib 15 mg	1	2018
Drug	ponatinib 30 mg	1	2018
Radiation	port-first	1	2016
Radiation	port-last	1	2016
Procedure	positron emission tomography (pet)	1	2018
Drug	post-medication for docetaxel)	1	2007
Diagnostic Test	post-sabr biopsy	1	2018
Drug	poziotinib once daily dosing	1	2020
Drug	poziotinib once daily dosing/twice daily dosing as determined in phase 1	1	2020
Drug	poziotinib twice daily dosing	1	2020
Drug	pralsetinib	1	2020
Drug	pralsetinib (blu-667)	1	2017
Drug	pre-surgical docetaxel	1	2005
Drug	pre-surgical docetaxel/cisplatin/adjuvant bevacizumab	1	2005
Drug	pre-surgical treatment with bevacizumab	1	2005
Drug	pre-surgical treatment with bevacizumab/chemotherapy	1	2005
Dietary Supplement	prealbumin goal-based ons	1	2018
Drug	premetrexed (alimta)	1	2006
Other	preoperative pulmonary rehabilitation	1	2019
Radiation	preoperative radiation	1	2014
Procedure	preoperative radiochemotherapy	1	2005
Procedure	preservation of the inferior pulmonary ligament	1	2019
Other	preventive intervention	1	2016
Drug	prexasertib	1	2010
Drug	prinomastat	1	2000
Drug	pro95780	1	2007
Drug	probiotic	1	2011
Drug	prolonged continuous infusion gemcitabine	1	2006
Radiation	prophylactic cranial irradiation	1	2011
Genetic	proteomic profiling	1	2007
Radiation	proton beam radiation therapy (pbt)	1	2014
Device	proton beam therapy	1	2017
Radiation	proton beam therapy rt	1	2019
Drug	ptk787	1	2005
Drug	ptk787/ zk 222584	1	2005
Drug	px-866	1	2010
Drug	pyrotinib maleate	1	2018
Device	q spect	1	2015
Biological	qbkpn ssi	1	2014
Drug	qbm076	1	2016
Behavioral	qigong	1	2016
Drug	ql1101	1	2017
Other	qlq-c30 global health	1	2020
Other	qlq-c30 global health/quality of life questionnaire	1	2020
Other	quality of life questionnaire	1	2020
Other	quality of life questionnaire, lung cancer-specific (qlq-lc13)	1	2020
Drug	quinacrine dihydrochloride - escalation dose	1	2013
Drug	quinacrine dihydrochloride - extension dose	1	2013
Drug	quisinostat	1	2015
Biological	racotumomab	1	2010
Procedure	radiation treatment	1	2005
Radiation	radiation with concurrent chemotherapy	1	2013
Radiation	radical radiotherapy - definitive local treatment.	1	2019
Radiation	radical radiotherapy (conventional rt	1	2015
Radiation	radical radiotherapy (conventional rt/sabr)	1	2015
Radiation	radiochemotherapy 1	1	2017
Radiation	radiochemotherapy 2	1	2017
Radiation	radiochemotherapy 3	1	2017
Radiation	radiochemotherapy 4	1	2017
Radiation	radiochemotherapy 5	1	2017
Radiation	radiochemotherapy 6	1	2017
Radiation	radiochemotherapy 7	1	2017
Procedure	radiological arm	1	2005
Procedure	radionuclide imaging	1	2008
Radiation	radiosurgery	1	2016
Radiation	radiotherapy (imrt	1	2014
Radiation	radiotherapy (imrt/3-d crt)	1	2014
Radiation	radiotherapy (sabr)	1	2017
Radiation	radiotherapy group	1	2018
Drug	radiotherapy)	1	2008
Other	radiotherapy/concurrent chemo-therapy	1	2010
Drug	radium-223 dichloride (xofigo, bay 88-8223)	1	2019
Drug	rapamycin (drug will be held)	1	2007
Other	rapid on-site evaluation	1	2013
Drug	rc48	1	2020
Device	real-time position transponder beacons	1	2017
Other	real time registry	1	2012
Other	real time registry/data feedback only	1	2012
Drug	rebimastat	1	2000
Biological	recombinant fowlpox-cea(6d)	1	2004
Biological	recombinant fowlpox-cea(6d)/tricom vaccine	1	2004
Biological	recombinant fowlpox gm-csf vaccine adjuvant	1	2004
Drug	recombinant human angiostatin protein	1	2002
Biological	recombinant human egf-rp64k	1	2016
Biological	recombinant human egf-rp64k/montanide isa 51 vaccine	1	2016
Drug	recombinant human erythropoietin (rhuepo)	1	2005
Biological	recombinant human interleukin-15	1	2012
Biological	recombinant interleukin-12	1	1999
Biological	recombinant prame protein	1	2013
Biological	recombinant prame protein/with the as15 adjuvant system gsk2302032a	1	2013
Biological	recombinant vaccinia-cea(6d)-tricom vaccine	1	2004
Drug	regn2810/ipi	1	2018
Drug	regn5093	1	2019
Other	regular diet	1	2018
Biological	relatlimab	1	2016
Drug	relatlimab 10 mg	1	2019
Drug	relatlimab 10 mg/ml intravenous solution	1	2019
Procedure	relaxation therapy	1	2019
Drug	reolysin	1	2012
Drug	reolysin (and safety run-in)	1	2012
Biological	reolysinâ®	1	2009
Radiation	response-driven adaptive radiation therapy	1	2015
Genetic	reverse transcriptase-polymerase chain reaction	1	2006
Device	rf ablation (rita medical systems model 1500x)	1	2008
Drug	rg1507	1	2008
Drug	rh-endostatin	1	2013
Drug	rhenium (re 188 p2045, bay86-5284)	1	2004
Drug	rhuph20	1	2018
Drug	rifampicin	1	2014
Drug	rifampin	1	2007
Drug	rituximab	1	2011
Drug	ro4929097	1	2010
Drug	ro5083945	1	2010
Drug	ro5490258	1	2011
Drug	ro6958688	1	2017
Drug	ro7198457	1	2020
Drug	rofecoxib	1	2006
Drug	rogaratinib	1	2018
Drug	romidepsin	1	2011
Diagnostic Test	ros1 ihc	1	2019
Drug	rosuvastatin	1	2014
Drug	rp2d (pbf-509	1	2015
Drug	rp2d (pbf-509/pdr001)_immuno naã¯ve	1	2015
Drug	rrx-001	1	2015
Drug	rsifn-co	1	2015
Drug	rucaparib	1	2019
Drug	rxdx-105	1	2018
Drug	s-3304	1	2004
Drug	s-588410	1	2015
Drug	s-8184 paclitaxel injectable emulsion	1	2002
Radiation	sabr)	1	2015
Drug	saf-189s	1	2020
Drug	sagopilone (bay86-5302, zk 219477)	1	2005
Other	saline	1	2009
Drug	salirasib	1	2007
Other	saliva	1	2019
Drug	sapanisertib	1	2015
Drug	saracatinib	1	2008
Biological	sargramostim	1	2000
Drug	satraplatin	1	2006
Drug	satraplatin in combination with paclitaxel	1	2005
Drug	sb8	1	2016
Radiation	sbrt 40.0 gy	1	2008
Radiation	sbrt 42.5 gy	1	2008
Radiation	sbrt 45.0 gy	1	2008
Radiation	sbrt 47.5 gy	1	2008
Radiation	sbrt 50.0 gy	1	2008
Radiation	sbrt 52.5 gy	1	2008
Radiation	sbrt 55.0 gy	1	2008
Radiation	sbrt 57.5 gy	1	2008
Radiation	sbrt 60.0 gy	1	2008
Radiation	sbrt with protons	1	2014
Radiation	sbrt with protons/photons	1	2014
Radiation	sbrt/tki	1	2018
Procedure	scannographic arm	1	2005
Drug	sch 727965	1	2008
Drug	screening platform	1	2019
Drug	sct-i10	1	2019
Drug	sdregn2810	1	2018
Drug	sdregn2810/ipi	1	2018
Drug	second-line chemotherapy	1	2011
Drug	second-line chemotherapy agents	1	2006
Procedure	segmentectomy	1	2007
Procedure	segmentectomy/wedge resection	1	2007
Drug	selenium	1	2001
Drug	selumetinib 75 mg	1	2012
Drug	selumetinib/docetaxel	1	2014
Drug	sgn-15	1	2003
Drug	sgn-15, docetaxel	1	2004
Drug	sgn-cd47m	1	2019
Drug	sh-1028	1	2018
Drug	sh t00268c	1	2005
Device	sham	1	2018
Other	sham control	1	2018
Drug	shark cartilage extract ae-941	1	2000
Drug	shenlingcao oral liquid	1	2018
Drug	sid530, taxotere	1	2009
Drug	sildenafil	1	2008
Drug	simultaneous chemoradiotherapy for an luo	1	2019
Radiation	single-fraction stereotactic body radiation therapy (sbrt)	1	2009
Drug	single arm	1	2019
Drug	sintilimab (approved)	1	2019
Drug	sintilimab (m1b)	1	2019
Drug	sintilimab/with docetaxel	1	2019
Drug	sintilimab/with docetaxel monotherapy	1	2019
Drug	sirolimus (rapamycin)	1	2009
Other	skin biopsy	1	2013
Behavioral	smoking cessation intervention	1	2017
Drug	sns-595 injection	1	2005
Drug	so-c101	1	2019
Drug	soblidotin	1	2003
Drug	sonidegib	1	2019
Drug	sorafenib (nexavar)	1	2009
Drug	sorafenib / docetaxel/carboplatin	1	2008
Other	spect-based treatment plan	1	2012
Diagnostic Test	spect-ct scan	1	2017
Procedure	spectroscopy	1	2008
Procedure	spontaneous ventilation	1	2018
Drug	ss1 (dsfv) pe38	1	2010
Drug	sta 4783	1	2004
Drug	sta 9090	1	2009
Other	staging of non-small cell lung carcinoma	1	2016
Combination Product	standard chemoradiotherapy	1	2018
Radiation	standard fractionation	1	2016
Drug	standard maintenance for squamous nsclc	1	2014
Drug	standard medical therapy	1	2019
Other	standard palliative care group	1	2009
Drug	standard platinum-based chemotherapy	1	2007
Radiation	stereotactic ablative radiotherapy (sar)	1	2017
Radiation	stereotactic body radiation therapy/surgery	1	2014
Radiation	stereotactic body radiotherapy (sabr)	1	2015
Radiation	stereotactic body radiotherapy (sbrt) 30 gy 3 fractions (#)	1	2018
Radiation	stereotactic body radiotherapy (sbrt) 54 gy 3 fractions (#)	1	2018
Radiation	stereotactic body radiotherapy (sbrt) dosed at the maximum tolerated dose	1	2018
Radiation	stereotactic body radiotherapy/sbrt	1	2019
Radiation	stereotactic radiation	1	2010
Radiation	stereotactic radiation therapy (srt)	1	2017
Radiation	stereotactic radiosurgery (srs)	1	2018
Radiation	sterotactic body radiotherapy	1	2019
Radiation	sterotactic body radiotherapy/sbrt	1	2019
Drug	subcutaneous (sc) sea-cd40	1	2015
Procedure	sublobar resection	1	2017
Procedure	subxiphoid uniportal vats	1	2017
Drug	sulijia	1	2017
Drug	sunitinib/rapamycin (drug will be held)	1	2007
Behavioral	support education activity	1	2018
Procedure	support group therapy	1	2018
Device	surgeon’s ‘standard of care’ stapler	1	2016
Procedure	surgical procedure	1	1999
Procedure	surgical removal of primary and	1	2019
Procedure	surgical removal of primary and/or of all oligometastases	1	2019
Procedure	surgical resection - definitive local treatment.	1	2019
Procedure	surgical resection of tumor	1	2016
Procedure	surgical staging	1	2007
Other	survivorship care plan	1	2020
Drug	sutent	1	2009
Drug	systemic therapy	1	2019
Drug	systemic therapy/standard of care	1	2019
Drug	tak-573	1	2019
Drug	tak-931	1	2017
Drug	talazoparib	1	2019
Drug	talazoparib tosylate	1	2019
Drug	talcum powder	1	2019
Drug	tarceva (erlotinib hcl, osi-774 )	1	2002
Drug	tarceva (erlotinib hydrochloride)	1	2009
Drug	tarceva (erlotinib)	1	2006
Drug	targeted molecular therapy	1	2016
Drug	targomirs	1	2015
Drug	tarloxotinib bromide	1	2019
Drug	tas-114	1	2016
Drug	taxane	1	2015
Drug	taxoprexin	1	2005
Drug	taxotereâ®	1	2006
Drug	tc-210 t cells	1	2019
Biological	tcr-t cells	1	2018
Biological	tecemotide	1	2009
Radiation	technetium-99	1	2004
Radiation	technetium 99m ethylenedicysteine-deoxyglucose	1	2009
Radiation	technetium tc-99m albumin aggregated	1	2016
Radiation	technetium tc-99m sulfur colloid	1	2016
Drug	telaglenastat	1	2019
Drug	telaglenastat hydrochloride	1	2019
Device	telecoaching	1	2019
Other	telehealth	1	2020
Behavioral	telephone-based intervention	1	2011
Drug	telisotuzumab vedotin	1	2018
Procedure	temla	1	2017
Drug	temoporfin	1	2013
Biological	tergenpumatucel-l	1	2015
Drug	tesevatinib	1	2015
Procedure	testing for mutation status	1	2010
Drug	tetrahydrouridine	1	2016
Drug	tetrahydrouridine (thu)	1	2017
Drug	tetrathiomolybdate	1	2013
Drug	tew-7197	1	2018
Drug	tg01	1	2007
Procedure	therapeutic bronchoscopy	1	2012
Combination Product	therapeutic lymphadenectomy (temla)	1	2013
Combination Product	therapeutic lymphadenectomy (temla)/stereotactic body radiation therapy (sbrt)	1	2013
Radiation	thoracic irradiation / pemetrexed	1	2007
Radiation	thoracic radiation	1	2017
Radiation	thoracic radiation therapy	1	2019
Radiation	thoracic rt	1	2019
Radiation	thoracic rt/durvalumab	1	2019
Procedure	thoracotomy	1	2015
Radiation	three-dimensional conformal radiation therapy	1	2001
Radiation	three dimensional conformal radiotherapy	1	2017
Drug	thymosin	1	2018
Drug	tinzaparin sodium 100 ui	1	2007
Drug	tinzaparin sodium 100 ui/kg/od for 12 weeks	1	2007
Drug	tiragolumab	1	2020
Drug	tislelizumab carboplatin nab-paxlitaxel	1	2018
Drug	tislelizumab carboplatin paxlitaxel	1	2018
Drug	tislelizumab,cisplatin	1	2018
Drug	tislelizumab,cisplatin/carboplatin ,pemetrexed	1	2018
Other	tissue oxygen measurement	1	2014
Drug	tivantinib	1	2010
Drug	tivozanib (av-951)	1	2009
Drug	tlk286 (telcyta) hcl for injection	1	2004
Drug	tlk286 in combination with docetaxel	1	2002
Drug	tlk286, cisplatin	1	2004
Biological	tn lymphocytes	1	2015
Drug	tno155	1	2019
Drug	tocilizumab	1	2017
Procedure	tomotherapy	1	2005
Drug	topotecan/docetaxel combination	1	2003
Drug	toripalimab injection (js001 ) combine with chemotherapy	1	2019
Drug	toripalimab injection(js001 )	1	2019
Dietary Supplement	total aa vs eaa	1	2010
Dietary Supplement	total aa vs eaa/leu	1	2010
Drug	tpc -vinorelbine,gemcitabine,docetaxel,	1	2011
Drug	tpc -vinorelbine,gemcitabine,docetaxel,/pemetrexed	1	2011
Drug	tpx-0046	1	2019
Drug	tq-a3334	1	2020
Drug	tq-b3101	1	2019
Drug	tqb2450	1	2019
Drug	tqb3456	1	2018
Drug	trail-r1 mab (trm-1;hgs-etr1)	1	2004
Drug	trail)	1	2007
Drug	trametinib 0.5 mg	1	2018
Drug	trametinib 1 mg	1	2018
Drug	trametinib 1.5 mg	1	2018
Drug	trametinib 2 mg	1	2018
Device	transcutaneous vagus nerve stimulation	1	2018
Procedure	transthoracic ultrasound	1	2010
Drug	trastuzumab deruxtecan	1	2017
Procedure	treatment by surgical resection	1	2015
Behavioral	treatment of cancer quality of life questionnaire c30	1	2015
Behavioral	treatment of cancer quality of life questionnaire lc-13	1	2015
Drug	treprilumab combination with platinum-containing dual-drug chemotherapy	1	2019
Biological	tricom vaccine	1	2004
Diagnostic Test	truesight oncology 500	1	2019
Drug	ts-1	1	2013
Drug	ts-1/cisplatin	1	2013
Drug	tsr-022	1	2017
Drug	tsr-042	1	2017
Other	tumor-infiltrating lymphocyte therapy	1	2017
Procedure	tumor-infiltrating lymphocytes (til)	1	2017
Other	tumor collection	1	2019
Procedure	tumor specimen for methylation analysis	1	2010
Drug	tvb-2640	1	2018
Drug	twice daily dosing as determined in phase 1	1	2020
Drug	ty-9591(10mg,40mg) qd. po	1	2019
Drug	u3-1287	1	2010
Drug	u3-1402	1	2017
Drug	ucpvax	1	2016
Drug	ufur	1	2008
Drug	ufur/iressa	1	2008
Procedure	ultrasound-guided transbronchial needle-delivered interstitial photodynamic therapy	1	2018
Procedure	ultrasound imaging	1	2008
Procedure	uniportal lobectomy with complete lymphadenectomy	1	2019
Other	urine collection	1	2019
Other	use of [18f]fdg - pet	1	2016
Other	use of [18f]fdg - pet/ct for the diagnosis/staging of non-small cell lung carcinoma	1	2016
Behavioral	usual care (routine chemotherapy cycles	1	2013
Behavioral	usual care (routine chemotherapy cycles/imaging studies)	1	2013
Drug	utidelone injection	1	2018
Biological	uv1 synthetic peptide vaccine	1	2013
Biological	uv1 synthetic peptide vaccine/gm-csf	1	2013
Device	v	1	2015
Device	v/q spect	1	2015
Biological	v934-ep	1	2008
Biological	v935	1	2008
Biological	v941	1	2019
Biological	vaccine	1	2012
Biological	vaccine / polyiclc	1	2012
Drug	val401	1	2016
Drug	valproic acid	1	2004
Drug	vandetanib induction	1	2008
Drug	vandetanib maintenance	1	2008
Drug	vandetanib, selumetinib	1	2012
Drug	varlilumab 3 mg	1	2019
Drug	varlilumab 3 mg/kg	1	2019
Drug	vatalanib	1	2008
Procedure	vats	1	2015
Drug	velcade/vorinostat	1	2008
Drug	velcadeâ„¢ (bortezomib) for injection (formerly ps-341)	1	2003
Biological	viagenpumatucel-l	1	2015
Device	video-assisted thoracoscopic lobectomy with powered vascular stapler	1	2017
Procedure	videothoracoscopy	1	1999
Device	viewray mr-linear accelerator	1	2019
Biological	vigilâ„¢	1	2010
Drug	vinblastine	1	2010
Drug	vindesine	1	1999
Drug	vinflunine	1	2005
Drug	vinorelbine oral formulation	1	2006
Drug	vinorelbine)	1	2006
Drug	vinorelbine, cisplatin	1	2017
Drug	vitamin a compound	1	2019
Drug	volitinib	1	2015
Radiation	volume modulated arc therapy	1	2014
Procedure	vomiting therapy	1	1999
Biological	vsv-ifnî²-nis	1	2018
Biological	vv1	1	2020
Drug	vx-001	1	2013
Drug	vx-970 (m6620)	1	2015
Drug	vx15	1	2017
Drug	vx15/2503 / avelumab	1	2017
Drug	w	1	2012
Drug	wbrt	1	2013
Procedure	wedge resection	1	2007
Drug	week	1	2012
Drug	weekly - concomitant chemoradiation 2gy	1	2012
Drug	weekly dp chemotherapy concurrent with thoracic radiotherapy	1	2018
Diagnostic Test	whole body 18f-fdg pet	1	2018
Diagnostic Test	whole body 18f-fdg pet/ct	1	2018
Radiation	whole brain radiation therapy	1	2012
Radiation	whole brain radiation(wbi)	1	2012
Radiation	whole brain radiotherapy	1	2015
Drug	with albumin-bound paclitaxel	1	2020
Combination Product	with bevacizumab	1	2020
Drug	with cisplatin	1	2013
Drug	with docetaxel	1	2019
Drug	with docetaxel monotherapy	1	2019
Drug	with egfr-tki	1	2019
Drug	with erlotinib	1	2014
Drug	with osimertinib	1	2019
Drug	with pemetrexed	1	2018
Other	with radiofrequency ablation	1	2019
Drug	with s-1 capsules	1	2017
Biological	with the as15 adjuvant system gsk2302032a	1	2013
Drug	with vinorelbine	1	2018
Drug	wx-0593 tablets	1	2017
Drug	x-396	1	2018
Drug	x-396(ensartinib)	1	2020
Drug	xl147 (sar245408)	1	2008
Drug	xl184	1	2008
Drug	xl765 (sar245409)	1	2008
Biological	xmab20717	1	2018
Biological	xmabâ®22841	1	2019
Biological	xmabâ®23104	1	2018
Drug	xmt-1001	1	2007
Drug	xmt-1522	1	2016
Biological	xmt-1592	1	2020
Biological	xofigo	1	2014
Drug	yangyinfang	1	2016
Drug	yh25448 240mg	1	2018
Drug	yiqifang	1	2016
Drug	yiqiyangyinfang	1	2016
Procedure	yoga	1	2019
Biological	young til	1	2014
Radiation	yttrium y 90 anti-cea monoclonal antibody ct84.66	1	2008
Drug	zactima (zd6474)	1	2007
Drug	zd1839 (iressa)	1	2006
Drug	zd4054	1	2008
Drug	zd6474 (vandetanib)	1	2006
Drug	zd6474 (vandetanib) 100mg	1	2005
Drug	zd6474 (vandetanib) 200mg	1	2005
Drug	zd6474 (vandetanib) 300mg	1	2005
Drug	zd6474, vandetanib	1	2008
Drug	zileuton	1	2003
Drug	zk 222584	1	2005
Drug	zn-e4	1	2018
Drug	zoledronic acid 4 mg	1	2005
Drug	zometa	1	2008
Radiation	zr-89 labelled durvalumab pet	1	2019
Radiation	zr-89 labelled durvalumab pet/ct	1	2019

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country	Study_Count
United States	860
China	271
NA	83
France	75
Canada	49
Japan	40
Korea, Republic of	40
United States\|Canada	40
Italy	30
United Kingdom	30
Germany	28
Netherlands	28
Taiwan	21
Greece	18
Spain	15
Belgium	14
Australia	12
Denmark	10
Switzerland	9
India	7
United States\|Spain	7
Israel	6
Poland	6
Singapore	6
United States\|Germany	6
United States\|United Kingdom	6
Russian Federation	5
United States\|Puerto Rico	5
Norway	4
United States\|China	4
Austria	3
Brazil	3
Sweden	3
United States\|France	3
United States\|India	3
United States\|Korea, Republic of	3
United States\|Netherlands	3
Argentina	2
China\|Japan\|Korea, Republic of\|Taiwan	2
China\|Korea, Republic of\|Taiwan	2
China\|Korea, Republic of\|Thailand	2
Finland	2
France\|Germany	2
Germany\|Switzerland	2
Hong Kong	2
Hong Kong\|Korea, Republic of\|Singapore\|Taiwan\|Thailand	2
Mexico	2
Romania	2
Turkey	2
United States\|Australia	2
United States\|Australia\|Brazil\|Bulgaria\|Canada\|China\|France\|Germany\|Greece\|Hong Kong\|Hungary\|Ireland\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	2
United States\|Australia\|Canada	2
United States\|Australia\|Japan\|Korea, Republic of	2
United States\|Australia\|Korea, Republic of\|Taiwan	2
United States\|Australia\|Peru\|Puerto Rico	2
United States\|Canada\|France\|Germany\|Italy\|Spain\|United Kingdom	2
United States\|Canada\|Germany	2
United States\|Canada\|Puerto Rico	2
United States\|Canada\|Spain\|United Kingdom	2
United States\|France\|Hungary\|Poland\|Spain	2
United States\|Georgia\|India\|Russian Federation\|Ukraine	2
United States\|Italy	2
United States\|Japan	2
United States\|Russian Federation	2
United States\|Taiwan	2
NA	1
Argentina\|Australia\|Austria\|Belgium\|Brazil\|China\|Finland\|France\|Germany\|Hungary\|India\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Poland\|Russian Federation\|Spain\|Taiwan\|Ukraine\|United Kingdom	1
Argentina\|Australia\|Austria\|Brazil\|China\|Colombia\|Denmark\|France\|Germany\|Greece\|Hungary\|India\|Ireland\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Mexico\|Netherlands\|Norway\|Poland\|Portugal\|Russian Federation\|Singapore\|Spain\|Sweden\|Taiwan\|Thailand\|Turkey\|United Kingdom	1
Argentina\|Australia\|Brazil\|Canada\|Romania\|Singapore	1
Argentina\|Belgium\|Brazil\|Bulgaria\|Canada\|China\|Colombia\|Czechia\|Denmark\|Germany\|India\|Ireland\|Italy\|Kazakhstan\|Luxembourg\|Mexico\|Poland\|Portugal\|Romania\|Slovakia\|Spain\|Switzerland\|United Kingdom\|Vietnam	1
Argentina\|Brazil\|Chile\|Mexico	1
Argentina\|Brazil\|China\|Colombia\|Costa Rica\|Denmark\|Greece\|Guatemala\|Italy\|Latvia\|Lebanon\|Malaysia\|Mexico\|Morocco\|Netherlands\|Panama\|Peru\|Philippines\|Poland\|Slovenia\|Spain\|Sweden\|United Arab Emirates\|United Kingdom	1
Australia\|Austria\|Belgium\|Canada\|China\|Czech Republic\|Denmark\|Finland\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Latvia\|Lithuania\|Netherlands\|New Zealand\|Philippines\|Poland\|Portugal\|Russian Federation\|Singapore\|South Africa\|Spain\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
Australia\|Austria\|Czechia\|Greece\|Hungary\|Israel\|Italy\|Poland\|Portugal\|Russian Federation\|Spain	1
Australia\|Belarus\|Brazil\|Bulgaria\|Chile\|China\|Colombia\|Czechia\|Georgia\|Greece\|Hungary\|Jordan\|Lebanon\|Malaysia\|Mexico\|Philippines\|Poland\|Romania\|Russian Federation\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine	1
Australia\|Belgium\|Canada\|Czech Republic\|Denmark\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Netherlands\|Poland\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
Australia\|Belgium\|China\|France\|Germany\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Taiwan\|Thailand	1
Australia\|Belgium\|China\|Germany\|Japan\|Singapore\|Spain	1
Australia\|Belgium\|Finland\|France\|Germany\|Greece\|India\|Italy\|Netherlands\|Poland\|Portugal\|Romania\|Spain\|Turkey\|United Kingdom	1
Australia\|Belgium\|France\|India\|Japan\|Malaysia\|Spain\|Taiwan\|Thailand	1
Australia\|Belgium\|France\|Italy\|Korea, Republic of\|Lithuania\|Netherlands\|Poland\|Romania\|Singapore\|Spain\|Taiwan\|United Kingdom	1
Australia\|Belgium\|Germany	1
Australia\|Brazil\|China\|Korea, Republic of\|Mexico\|Taiwan	1
Australia\|Brazil\|Czech Republic\|France\|Germany\|Italy\|Korea, Republic of\|South Africa\|Taiwan\|United Kingdom	1
Australia\|Canada	1
Australia\|China\|Egypt\|India\|Korea, Republic of\|Romania\|Taiwan\|Turkey	1
Australia\|China\|Hong Kong\|Indonesia\|Korea, Republic of\|Philippines\|Taiwan\|Thailand	1
Australia\|Hong Kong\|Korea, Republic of\|Singapore	1
Australia\|Italy\|Mexico\|Spain	1
Australia\|Netherlands\|Singapore	1
Australia\|New Zealand	1
Australia\|New Zealand\|Poland\|Russian Federation\|Thailand	1
Australia\|New Zealand\|Spain	1
Australia\|Singapore	1
Australia\|Taiwan	1
Australia\|United Kingdom	1
Australia\|United States\|Austria\|Belarus\|Brazil\|Canada\|Croatia\|Czechia\|Denmark\|Egypt\|Estonia\|Finland\|France\|Germany\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Latvia\|Lithuania\|Mexico\|Netherlands\|New Zealand\|Norway\|Poland\|Portugal\|Puerto Rico\|Russian Federation\|Serbia\|Slovakia\|South Africa\|Spain\|Sweden\|Switzerland\|Turkey\|Ukraine\|United Kingdom	1
Australia\|United States\|Belgium\|Brazil\|Bulgaria\|Canada\|China\|Czechia\|France\|Germany\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Philippines\|Poland\|Portugal\|Romania\|Russian Federation\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom\|Vietnam	1
Austria\|Belarus\|Belgium\|Bulgaria\|China\|Croatia\|Czechia\|Denmark\|France\|Georgia\|Germany\|Greece\|India\|Israel\|Italy\|Korea, Republic of\|Lithuania\|Poland\|Portugal\|Romania\|Russian Federation\|Slovakia\|South Africa\|Spain\|Switzerland\|Ukraine\|United Kingdom	1
Austria\|Belgium\|Denmark\|France\|Germany\|Netherlands\|Norway\|Switzerland\|United Kingdom	1
Austria\|Belgium\|Denmark\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Netherlands\|Spain\|Switzerland\|United Kingdom	1
Austria\|Belgium\|France\|Germany\|Ireland\|Italy\|Poland\|Slovenia\|Spain\|Switzerland\|United Kingdom	1
Austria\|Denmark\|Finland\|Greece\|Hungary\|Ireland\|Poland\|Portugal\|Romania\|Russian Federation\|Spain\|Sweden\|United Kingdom	1
Austria\|Denmark\|France\|Germany\|Italy\|Spain	1
Austria\|Germany\|Greece\|Italy\|Netherlands\|Spain	1
Austria\|Germany\|Hungary\|Spain\|Sweden	1
Bahamas\|Canada	1
Bangladesh	1
Belarus\|Bulgaria\|Croatia\|Georgia\|Greece\|Hungary\|India\|Latvia\|Malaysia\|Philippines\|Poland\|Russian Federation\|Serbia\|Slovakia\|Thailand\|Turkey\|Ukraine	1
Belarus\|Georgia\|Germany\|Hungary\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|Serbia\|Spain\|Taiwan\|Thailand\|Ukraine	1
Belarus\|Hungary\|Poland\|Russian Federation\|Ukraine	1
Belarus\|India\|Russian Federation\|Ukraine	1
Belarus\|Russian Federation	1
Belgium\|Bosnia and Herzegovina\|Bulgaria\|Egypt\|Estonia\|Germany\|Hungary\|Italy\|Lithuania\|Poland\|Romania\|Saudi Arabia\|Slovakia\|Sweden\|Taiwan	1
Belgium\|Bulgaria\|Estonia\|France\|Germany\|Hong Kong\|Ireland\|Italy\|Poland\|Russian Federation\|Singapore\|Spain\|Taiwan\|United Kingdom	1
Belgium\|Bulgaria\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Korea, Republic of\|Norway\|Poland\|Portugal\|Russian Federation\|Slovakia\|Spain\|Turkey	1
Belgium\|China\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Portugal\|Spain\|Taiwan\|Thailand\|United Kingdom	1
Belgium\|Czech Republic\|Egypt\|France\|Germany\|Greece\|Italy\|Netherlands\|Poland\|South Africa\|Spain\|Switzerland	1
Belgium\|Czech Republic\|France\|Germany\|Ireland\|Italy\|Poland\|Spain	1
Belgium\|Denmark\|Netherlands\|Sweden\|United Kingdom	1
Belgium\|Estonia\|Finland\|France\|Germany\|Greece\|Italy\|Latvia\|Lithuania\|Netherlands\|Norway\|Poland\|Spain\|United Kingdom\|	1
Belgium\|France	1
Belgium\|France\|Greece\|Spain	1
Belgium\|France\|Italy\|Netherlands\|United Kingdom	1
Belgium\|France\|Spain	1
Belgium\|Germany\|Luxembourg	1
Belgium\|Germany\|Netherlands	1
Belgium\|Germany\|Netherlands\|Spain\|Switzerland	1
Belgium\|Germany\|Switzerland\|United Kingdom	1
Belgium\|Ireland\|Italy\|Netherlands\|Spain\|Switzerland	1
Belgium\|Ireland\|Spain	1
Belgium\|Netherlands	1
Belgium\|Netherlands\|United Kingdom	1
Belgium\|Spain	1
Belgium\|Spain\|United Kingdom	1
Belgium\|United States\|Argentina\|Brazil\|Canada\|China\|Croatia\|Denmark\|Estonia\|France\|Germany\|Hong Kong\|Indonesia\|Italy\|Latvia\|Malaysia\|Mexico\|Philippines\|Singapore\|Slovenia\|Spain\|Sweden\|Switzerland\|Thailand\|Turkey	1
Belgium\|United States\|Australia\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Romania\|Russian Federation\|Spain\|Taiwan\|Ukraine	1
Belgium\|United States\|Canada\|France\|Italy\|Poland\|Spain\|United Kingdom	1
Brazil\|Bulgaria\|China\|Lithuania\|Mexico\|New Zealand\|Poland\|Russian Federation\|Slovakia\|Turkey	1
Brazil\|Canada	1
Brazil\|China\|Hong Kong\|India\|Korea, Republic of\|Taiwan\|United Kingdom	1
Bulgaria	1
Bulgaria\|Czech Republic\|France\|Romania\|Ukraine	1
Canada\|Argentina\|Australia\|Belgium\|Brazil\|Bulgaria\|Czech Republic\|France\|Germany\|Greece\|Hong Kong\|Hungary\|Israel\|Italy\|Poland\|Russian Federation\|Spain\|Taiwan\|Thailand\|United Kingdom	1
Canada\|Australia\|Czech Republic\|Netherlands\|United Kingdom	1
Canada\|Germany\|Hong Kong\|Italy\|Singapore\|Taiwan	1
Canada\|Hungary\|Poland\|Romania	1
Canada\|Italy	1
Canada\|Korea, Republic of\|Taiwan	1
Canada\|United States\|Australia\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Mexico\|Russian Federation\|Spain\|Taiwan\|Turkey\|United Kingdom	1
Chile\|China\|Croatia\|Egypt\|India\|Malaysia\|Malta\|Morocco\|Pakistan\|Panama\|Peru\|South Africa\|Tunisia	1
Chile\|France\|Italy\|Korea, Republic of\|Latvia\|New Zealand\|Poland\|Spain\|United Kingdom	1
China\|Australia\|Korea, Republic of	1
China\|Denmark\|Egypt\|France\|Germany\|Netherlands\|Spain\|Switzerland\|Turkey	1
China\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Japan\|Korea, Republic of\|Russian Federation\|Spain\|Taiwan	1
China\|Hong Kong\|India\|Korea, Republic of\|Mexico\|Philippines\|Poland\|Russian Federation\|Taiwan\|Turkey	1
China\|Hong Kong\|India\|Philippines\|Taiwan\|Thailand\|Vietnam	1
China\|Hong Kong\|India\|Singapore\|Taiwan	1
China\|Hong Kong\|Indonesia\|Japan\|Malaysia\|Philippines\|Singapore\|Taiwan\|Thailand	1
China\|Hong Kong\|Indonesia\|Korea, Republic of\|Philippines\|Taiwan\|Thailand	1
China\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Poland\|Spain	1
China\|Hong Kong\|Malaysia\|Taiwan\|Thailand	1
China\|Hong Kong\|Russian Federation\|Singapore	1
China\|Italy\|Korea, Republic of\|Malaysia\|Singapore\|Spain\|Taiwan	1
China\|Korea, Republic of	1
China\|Korea, Republic of\|Malaysia\|Singapore\|Thailand	1
China\|Malaysia	1
China\|Malaysia\|Philippines	1
China\|Thailand	1
China\|United States\|Argentina\|Brazil\|Bulgaria\|Chile\|Denmark\|Finland\|Greece\|Hong Kong\|India\|Israel\|Japan\|Korea, Republic of\|Malaysia\|Mexico\|Peru\|Philippines\|Poland\|Portugal\|Qatar\|Romania\|Russian Federation\|Saudi Arabia\|Singapore\|Sweden\|Turkey\|Ukraine\|United Kingdom	1
Cyprus	1
Czech Republic\|Australia\|Austria\|Belgium\|Canada\|Chile\|China\|Denmark\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Lithuania\|Malaysia\|Netherlands\|New Zealand\|Poland\|Romania\|Russian Federation\|Slovakia\|Slovenia\|South Africa\|Spain\|Ukraine\|United Kingdom\|Venezuela	1
Czech Republic\|Germany\|Netherlands	1
Czech Republic\|United States\|Australia\|Bulgaria\|Canada\|France\|Germany\|Greece\|Hungary\|India\|Italy\|Korea, Republic of\|Latvia\|Malaysia\|Philippines\|Poland\|Romania\|Russian Federation\|Singapore\|Spain\|Taiwan\|Turkey\|United Kingdom	1
Czechia\|France\|Germany\|Greece\|Italy\|Poland\|Romania\|Spain	1
Denmark\|France\|Germany\|Italy\|Korea, Republic of\|Netherlands\|Spain\|Taiwan\|United Kingdom	1
Denmark\|Germany\|Italy\|Spain\|Sweden	1
Denmark\|United Kingdom	1
Egypt	1
Egypt\|Estonia\|Argentina\|Australia\|Austria\|Bosnia and Herzegovina\|Brazil\|Canada\|China\|Colombia\|Czech Republic\|Denmark\|Ecuador\|Finland\|France\|Germany\|Hong Kong\|Hungary\|Iceland\|Israel\|Italy\|Latvia\|Lebanon\|Lithuania\|Mexico\|Netherlands\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Slovakia\|Slovenia\|Spain\|Sweden\|Switzerland\|Taiwan\|Turkey\|United Kingdom\|Venezuela	1
Egypt\|Lebanon\|Saudi Arabia	1
Egypt\|Malaysia\|Philippines\|Poland\|Romania\|Serbia\|Thailand	1
Finland\|Germany\|Italy\|Netherlands\|United Kingdom	1
France\|Germany\|Greece\|Italy\|Korea, Republic of\|Netherlands\|Russian Federation\|Spain\|Sweden\|Switzerland\|Turkey\|United Arab Emirates	1
France\|Germany\|Hungary\|Poland	1
France\|Germany\|Italy\|Netherlands\|Spain\|United Kingdom	1
France\|Germany\|Italy\|Spain	1
France\|Germany\|Italy\|Spain\|United Kingdom	1
France\|Germany\|Spain	1
France\|Italy\|Spain	1
France\|Jordan\|Poland\|Slovenia\|Spain	1
France\|Korea, Republic of\|Spain	1
France\|Korea, Republic of\|Spain\|United Kingdom	1
France\|Switzerland\|United Kingdom	1
France\|United States\|Australia\|Austria\|Belgium\|Canada\|Germany\|Netherlands	1
France\|United States\|Belgium\|China\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Taiwan\|United Kingdom	1
Georgia	1
Germany\|Hong Kong\|United States\|Australia\|Canada\|China\|France\|Hungary\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	1
Germany\|Hungary\|United States\|Austria\|Belgium\|Canada\|Czechia\|France\|Italy\|Japan\|Korea, Republic of\|Philippines\|Poland\|Singapore\|Spain\|Taiwan\|Thailand\|United Kingdom	1
Germany\|Italy	1
Germany\|Italy\|Netherlands\|Poland\|United Kingdom	1
Germany\|Italy\|Poland\|United Kingdom	1
Germany\|Netherlands\|Spain\|Switzerland	1
Germany\|Poland	1
Germany\|Spain	1
Germany\|United Kingdom	1
Germany\|United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|Croatia\|France\|Hong Kong\|Hungary\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Peru\|Poland\|Russian Federation\|Serbia\|South Africa\|Spain\|Taiwan\|Ukraine\|United Kingdom	1
Germany\|United States\|Argentina\|Austria\|Belgium\|Brazil\|Denmark\|France\|Greece\|Italy\|Japan\|Lebanon\|Mexico\|Netherlands\|Oman\|Slovakia\|Spain\|United Arab Emirates	1
Germany\|United States\|Argentina\|Belgium\|South Africa\|United Kingdom	1
Germany\|United States\|Brazil\|China\|France\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|Serbia\|Spain\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
Greece\|Germany\|Australia\|Austria\|Belgium\|Canada\|Czech Republic\|Estonia\|Finland\|France\|Hong Kong\|Hungary\|Italy\|Poland\|Spain	1
Hong Kong\|Italy\|United States\|Australia\|France\|Germany\|Japan\|Korea, Republic of\|Poland\|Russian Federation\|Singapore\|Spain\|Taiwan\|United Kingdom	1
Hong Kong\|Korea, Republic of\|Malaysia\|Philippines\|Singapore\|Taiwan\|Thailand	1
Hong Kong\|Korea, Republic of\|Malaysia\|Singapore\|Taiwan\|Thailand	1
Hong Kong\|Korea, Republic of\|Taiwan\|Thailand	1
Hungary\|Brazil\|Bulgaria\|Chile\|Georgia\|Greece\|India\|Lebanon\|Malaysia\|Mexico\|Philippines\|Russian Federation\|Serbia\|Spain\|Thailand\|Turkey\|Ukraine	1
Hungary\|Serbia\|Spain	1
India\|Italy\|United States\|Argentina\|Belgium\|Chile\|France\|Germany\|Hungary\|Netherlands\|Norway\|Poland\|Puerto Rico\|Romania\|Russian Federation\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
India\|Japan\|United States\|Belgium\|Hungary\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Russian Federation\|Ukraine\|United Kingdom	1
Ireland	1
Ireland\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Switzerland	1
Ireland\|United Kingdom	1
Israel\|Italy\|United States\|Belgium\|Canada\|China\|France\|Germany\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Spain\|United Kingdom	1
Italy\|Netherlands\|Poland\|South Africa\|United Kingdom	1
Italy\|Netherlands\|Spain\|United Kingdom	1
Italy\|United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Chile\|Czechia\|Denmark\|France\|Germany\|Hungary\|Mexico\|Netherlands\|Peru\|Poland\|Romania\|Russian Federation\|Spain\|Sweden\|United Kingdom	1
Japan\|Korea, Republic of\|Singapore\|Taiwan	1
Japan\|Korea, Republic of\|Taiwan	1
Japan\|United States\|Argentina\|Australia\|Belgium\|Brazil\|Bulgaria\|Chile\|Colombia\|Croatia\|Czechia\|Denmark\|France\|Hungary\|Israel\|Italy\|Korea, Republic of\|Mexico\|Peru\|Poland\|Romania\|Russian Federation\|Slovakia\|South Africa\|Spain\|Switzerland\|Taiwan\|Turkey\|United Kingdom	1
Jordan\|Lebanon	1
Kazakhstan\|Russian Federation	1
Korea, Republic of\|Poland	1
Malaysia\|Australia\|Austria\|Belgium\|Canada\|Chile\|China\|Czech Republic\|Denmark\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Lithuania\|New Zealand\|Poland\|Romania\|Russian Federation\|Slovakia\|Slovenia\|South Africa\|Spain\|Ukraine\|United Kingdom\|Venezuela	1
Mexico\|Brazil\|Czechia\|Hungary\|India\|Japan\|Korea, Republic of\|Peru\|Philippines\|Poland\|Russian Federation\|Thailand\|Turkey\|Vietnam	1
Netherlands\|Spain\|Switzerland	1
Netherlands\|United Kingdom	1
Peru\|United States\|Argentina\|Australia\|Brazil\|Canada\|Italy\|Korea, Republic of\|New Zealand\|Philippines\|Taiwan\|Thailand	1
Poland\|Albania\|Argentina\|Australia\|Austria\|Belgium\|Bosnia and Herzegovina\|Brazil\|Bulgaria\|Chile\|China\|Colombia\|Croatia\|Czech Republic\|Ecuador\|Egypt\|Estonia\|Finland\|Germany\|Greece\|Guatemala\|Hong Kong\|Hungary\|India\|Indonesia\|Ireland\|Israel\|Italy\|Korea, Republic of\|Latvia\|Lithuania\|Malaysia\|Mexico\|Netherlands\|New Zealand\|Panama\|Peru\|Portugal\|Romania\|Russian Federation\|Saudi Arabia\|Serbia\|Slovakia\|Slovenia\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|Uruguay\|Venezuela	1
Poland\|Bulgaria\|France\|Greece\|Hungary\|Italy\|Norway\|Portugal\|Romania\|Spain\|Switzerland\|Turkey\|United Kingdom	1
Poland\|Hungary\|Russian Federation	1
Poland\|Romania\|South Africa\|Ukraine	1
Portugal	1
Russian Federation\|Ukraine	1
Serbia	1
Slovakia\|Spain\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Chile\|Czech Republic\|France\|Germany\|Hong Kong\|Hungary\|Ireland\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Russian Federation\|Singapore\|Sweden\|Switzerland\|Taiwan\|Turkey\|Ukraine\|United Kingdom	1
Spain\|Austria\|Belgium\|Brazil\|Canada\|China\|Cyprus\|Finland\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Mexico\|Netherlands\|Switzerland\|United Kingdom	1
Spain\|Belgium\|France\|Germany\|Italy\|Poland\|United Kingdom	1
Spain\|Switzerland\|Argentina\|United States\|Australia\|Austria\|Brazil\|Canada\|Chile\|Czechia\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Mexico\|Norway\|Peru\|Poland\|Romania\|Russian Federation\|Singapore	1
Spain\|United States\|Australia\|Belgium\|France\|Italy\|Korea, Republic of\|Taiwan\|United Kingdom	1
Spain\|United States\|Australia\|Canada\|Denmark\|Estonia\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Poland\|Russian Federation\|Switzerland\|Turkey\|Ukraine\|United Kingdom	1
Spain\|United States\|Canada\|Germany\|Korea, Republic of\|Taiwan	1
Sweden\|United Kingdom	1
Taiwan\|United States\|Argentina\|Austria\|Canada\|Chile\|China\|Denmark\|France\|Germany\|Greece\|Hungary\|India\|Ireland\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Portugal\|Singapore\|Spain\|Turkey\|United Kingdom	1
Ukraine\|United Kingdom\|United States\|Austria\|Belgium\|Bulgaria\|Germany\|Hungary\|Israel\|Italy\|Lithuania\|Romania\|Slovenia	1
United Kingdom\|United States\|Belgium\|France\|Germany\|Korea, Republic of\|Poland\|Spain\|Taiwan	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|France\|Germany\|Hungary\|Israel\|Italy\|Mexico\|Netherlands\|Peru\|Poland\|Portugal\|Romania\|Russian Federation\|Spain\|Sweden\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|France\|Germany\|Israel\|Italy\|Japan\|Latvia\|Lithuania\|Mexico\|Netherlands\|Peru\|Portugal\|Russian Federation\|Singapore\|Slovakia\|Spain\|Taiwan\|Ukraine	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Chile\|France\|Germany\|Hong Kong\|Hungary\|Ireland\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Peru\|Philippines\|Romania\|Russian Federation\|Taiwan\|Thailand\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Czechia\|Finland\|France\|Germany\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Romania\|Spain\|Sweden\|Switzerland\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Denmark\|Finland\|France\|Germany\|Greece\|Hungary\|India\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Portugal\|Puerto Rico\|Spain\|Sweden\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|France\|Chile\|China\|Colombia\|Czechia\|Finland\|Germany\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Mexico\|Netherlands\|Peru\|Poland\|Romania\|Russian Federation\|Saudi Arabia\|South Africa\|Spain\|Switzerland\|Taiwan\|Turkey\|United Arab Emirates\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Chile\|Colombia\|Czech Republic\|Egypt\|Former Yugoslavia\|France\|Greece\|Israel\|Italy\|Japan\|Lithuania\|Macedonia, The Former Yugoslav Republic of\|Morocco\|Norway\|Philippines\|Poland\|Portugal\|Slovenia\|South Africa\|Spain\|Sweden\|Switzerland\|Tunisia	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Bulgaria\|Chile\|China\|France\|Hungary\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Latvia\|Lithuania\|Malaysia\|Netherlands\|Peru\|Portugal\|Romania\|Russian Federation\|Spain\|Taiwan\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Canada\|China\|France\|Germany\|Hong Kong\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Philippines\|Singapore\|Spain\|Taiwan\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Canada\|Czech Republic\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Bulgaria\|Canada\|Chile\|China\|Czech Republic\|Estonia\|Finland\|France\|Germany\|Greece\|Hong Kong\|Hungary\|India\|Italy\|Korea, Republic of\|Malaysia\|Netherlands\|Poland\|Portugal\|Romania\|Russian Federation\|Singapore\|Spain\|Sweden\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Canada\|Chile\|China\|Colombia\|Czechia\|Denmark\|Finland\|France\|Germany\|Greece\|Hong Kong\|Hungary\|Iceland\|India\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Malaysia\|Netherlands\|Norway\|Philippines\|Poland\|Portugal\|Romania\|Russian Federation\|Singapore\|Slovakia\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|United Kingdom\|Vietnam	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Canada\|Colombia\|France\|Germany\|Japan\|Korea, Republic of\|New Zealand\|Poland\|Romania\|Russian Federation\|Spain\|Taiwan\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Canada\|France\|Germany\|Hungary\|Italy\|Japan\|Korea, Republic of\|New Zealand\|Norway\|Poland\|Russian Federation\|Spain\|Switzerland\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Denmark\|France\|Germany\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Poland\|Russian Federation\|Serbia\|Spain\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine	1
United States\|Argentina\|Australia\|Austria\|Canada\|Chile\|Czechia\|France\|Germany\|Hungary\|Ireland\|Italy\|Mexico\|Netherlands\|Peru\|Poland\|Romania\|Russian Federation\|Spain\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Bulgaria\|Hong Kong\|Israel\|Italy\|Mexico\|Philippines\|Romania\|Singapore\|Spain\|Taiwan\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|China\|Czechia\|Denmark\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Japan\|Jordan\|Korea, Republic of\|Lebanon\|Netherlands\|Poland\|Russian Federation\|Singapore\|Spain\|Taiwan	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|China\|France\|Germany\|Ireland\|Italy\|Japan\|Mexico\|Poland\|Romania\|Russian Federation\|Spain\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|Costa Rica\|France\|Germany\|Hong Kong\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|New Zealand\|Panama\|Peru\|Poland\|Russian Federation\|Serbia\|Singapore\|Spain\|Taiwan\|Thailand\|Turkey	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|France\|Germany\|Greece\|Ireland\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Puerto Rico\|Romania\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Greece\|Hong Kong\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Romania\|Russian Federation\|Singapore\|Spain\|Taiwan\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Hong Kong\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Peru\|Poland\|Russian Federation\|Spain\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Ireland\|Italy\|Japan\|Mexico\|Netherlands\|Poland\|Puerto Rico\|Romania\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|China\|France\|Germany\|Greece\|India\|Ireland\|Korea, Republic of\|Netherlands\|Portugal\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Colombia\|France\|Germany\|Hong Kong\|Korea, Republic of\|Mexico\|Philippines\|Singapore\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Canada\|Chile\|China\|France\|Hungary\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Russian Federation\|Spain\|Turkey	1
United States\|Argentina\|Australia\|Belgium\|Canada\|China\|Czechia\|France\|Germany\|Hong Kong\|India\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Russian Federation\|Singapore\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Colombia\|France\|Germany\|Greece\|Hong Kong\|India\|Israel\|Italy\|Mexico\|Philippines\|Portugal\|South Africa\|Spain\|Sweden\|Taiwan\|United Kingdom\|Venezuela	1
United States\|Argentina\|Australia\|Bosnia and Herzegovina\|Brazil\|Canada\|Chile\|Colombia\|Ecuador\|Germany\|Hong Kong\|Hungary\|Ireland\|Korea, Republic of\|Latvia\|Macedonia, The Former Yugoslav Republic of\|Malaysia\|Mexico\|Moldova, Republic of\|Netherlands\|New Zealand\|Panama\|Peru\|Philippines\|Poland\|Romania\|Serbia\|Sweden\|Taiwan\|Thailand\|Turkey\|Ukraine	1
United States\|Argentina\|Australia\|Brazil\|Canada\|Chile\|China\|Germany\|Greece\|Israel\|Mexico\|New Zealand\|Romania\|Singapore\|South Africa\|Sweden\|Thailand	1
United States\|Argentina\|Australia\|Brazil\|Canada\|Chile\|Colombia\|France\|Germany\|Hungary\|Ireland\|Italy\|Korea, Republic of\|Latvia\|Mexico\|Peru\|Poland\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Canada\|Chile\|France\|Germany\|Hungary\|Israel\|Italy\|Netherlands\|Russian Federation\|Spain\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Canada\|China\|Czechia\|India\|Japan\|Korea, Republic of\|Peru\|Philippines\|Russian Federation\|Slovakia\|South Africa\|Taiwan\|Thailand\|United Kingdom\|Vietnam	1
United States\|Argentina\|Australia\|Brazil\|Canada\|China\|Denmark\|France\|Germany\|Hong Kong\|India\|Indonesia\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Norway\|Philippines\|Spain\|Taiwan\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Chile\|Germany\|Italy\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Chile\|India	1
United States\|Argentina\|Australia\|Canada\|Chile\|China\|France\|Germany\|Israel\|Japan\|Korea, Republic of\|New Zealand\|Poland\|Russian Federation\|Spain\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Canada\|Czechia\|Denmark\|Finland\|Germany\|Hungary\|Israel\|Japan\|Korea, Republic of\|Netherlands\|New Zealand\|Russian Federation\|South Africa\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|France\|Germany\|Italy\|Korea, Republic of\|Russian Federation\|Spain\|Taiwan	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|China\|France\|Germany\|Greece\|Hong Kong\|Hungary\|India\|Indonesia\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Pakistan\|Peru\|Philippines\|Poland\|Russian Federation\|Singapore\|South Africa\|Spain\|Sweden\|Taiwan\|Thailand\|Turkey\|United Kingdom	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|China\|France\|Germany\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Philippines\|Romania\|Russian Federation\|Spain\|Taiwan\|Thailand\|Vietnam	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|China\|Denmark\|France\|Germany\|Greece\|India\|Indonesia\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Mexico\|Netherlands\|Portugal\|Singapore\|Spain\|Thailand\|Turkey\|Vietnam	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|France\|Germany\|Israel\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Mexico\|Netherlands\|Norway\|Poland\|Russian Federation\|Singapore\|Spain\|Sweden\|Switzerland\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Austria\|Brazil\|Bulgaria\|Canada\|Chile\|China\|Colombia\|Czechia\|France\|Germany\|Greece\|Guatemala\|Hong Kong\|Hungary\|Iceland\|India\|Israel\|Italy\|Japan\|Jordan\|Korea, Republic of\|Lebanon\|Malaysia\|Mexico\|Norway\|Panama\|Peru\|Philippines\|Poland\|Portugal\|Romania\|Russian Federation\|South Africa\|Spain\|Switzerland\|Taiwan\|Thailand\|Turkey\|United Kingdom\|Vietnam	1
United States\|Argentina\|Austria\|Brazil\|Canada\|Chile\|Finland\|France\|Germany\|Greece\|Guatemala\|Hungary\|Italy\|Japan\|Korea, Republic of\|Netherlands\|New Zealand\|Norway\|Panama\|Poland\|Portugal\|Russian Federation\|Serbia\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Austria\|Brazil\|Canada\|France\|Germany\|Greece\|Hungary\|India\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|New Zealand\|Norway\|Poland\|Puerto Rico\|Romania\|Russian Federation\|Spain\|Sweden\|Switzerland\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Austria\|Canada\|Chile\|China\|Croatia\|France\|Germany\|Greece\|Hong Kong\|Italy\|Korea, Republic of\|Mexico\|Romania\|Russian Federation\|Spain\|Sweden\|Taiwan\|Thailand	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|China\|France\|Germany\|Greece\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Spain\|Taiwan\|Turkey\|Ukraine	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|China\|France\|Germany\|Ireland\|Italy\|Japan\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|South Africa\|Spain\|Taiwan\|Ukraine\|United Kingdom	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Japan\|Netherlands\|Singapore\|Spain\|Taiwan\|Thailand\|Turkey\|United Kingdom	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|France\|Germany\|Israel\|Italy\|Netherlands\|Spain\|Turkey	1
United States\|Argentina\|Brazil\|Bulgaria\|Chile\|Colombia\|Greece\|Hungary\|Mexico\|Peru\|Poland\|Romania\|Russian Federation\|Spain\|Turkey\|Ukraine	1
United States\|Argentina\|Brazil\|Bulgaria\|Chile\|Croatia\|Egypt\|Germany\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Mexico\|Philippines\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|South Africa\|Spain\|Thailand\|Turkey\|Ukraine\|United Kingdom\|Vietnam	1
United States\|Argentina\|Brazil\|Canada\|China\|France\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Romania\|Spain\|Taiwan\|Turkey	1
United States\|Argentina\|Brazil\|China\|Hungary\|India\|Japan\|Korea, Republic of\|Malaysia\|Peru\|Russian Federation\|Spain\|Taiwan\|Thailand\|Turkey\|Vietnam	1
United States\|Argentina\|Brazil\|Czech Republic\|Hungary\|India	1
United States\|Argentina\|Canada\|France\|Korea, Republic of\|Poland\|Spain\|Taiwan	1
United States\|Argentina\|China\|Korea, Republic of	1
United States\|Argentina\|France\|Germany\|Israel\|Italy\|Latvia\|Malaysia\|Mexico\|Philippines\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|France\|Germany\|Israel\|Italy\|Latvia\|Spain\|United Kingdom	1
United States\|Argentina\|France\|Hungary\|Spain\|Thailand	1
United States\|Australia\|Austria\|Belarus\|Bosnia and Herzegovina\|China\|Denmark\|Egypt\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Japan\|Kazakhstan\|Korea, Republic of\|Latvia\|Lebanon\|North Macedonia\|Poland\|Portugal\|Romania\|Russian Federation\|Saudi Arabia\|Singapore\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Colombia\|Czechia\|Germany\|Greece\|India\|Italy\|Korea, Republic of\|Lebanon\|Malaysia\|Netherlands\|Poland\|Russian Federation\|Spain\|Taiwan\|Thailand\|Turkey\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Croatia\|France\|Germany\|Greece\|Hungary\|Italy\|Korea, Republic of\|Philippines\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Singapore\|Slovakia\|South Africa\|Spain\|Taiwan\|Thailand\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Croatia\|France\|Germany\|Greece\|Hungary\|Italy\|Poland\|Portugal\|Romania\|Russian Federation\|Slovakia\|South Africa\|Spain\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|France\|Israel\|Italy\|Spain	1
United States\|Australia\|Austria\|Brazil\|Bulgaria\|China\|Croatia\|Czech Republic\|Germany\|Greece\|Hungary\|India\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Romania\|Spain\|Taiwan\|Turkey	1
United States\|Australia\|Austria\|Brazil\|China\|France\|Germany\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Poland\|Russian Federation\|Serbia\|Slovenia\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Australia\|Austria\|Canada\|China\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Spain\|Sweden\|Taiwan	1
United States\|Australia\|Austria\|Canada\|Denmark\|France\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Luxembourg\|Netherlands\|Norway\|Singapore\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Canada\|France\|Italy\|Spain\|Switzerland	1
United States\|Australia\|Belarus\|Belgium\|Canada\|Czechia\|France\|Germany\|Hungary\|Israel\|Italy\|Poland\|Russian Federation\|Serbia\|Slovenia\|Spain\|Ukraine	1
United States\|Australia\|Belgium\|Bosnia and Herzegovina\|Bulgaria\|Canada\|France\|Georgia\|Germany\|Hong Kong\|Italy\|Japan\|Netherlands\|Singapore\|Slovenia\|Spain\|Switzerland\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|China\|Colombia\|Croatia\|Cyprus\|Czechia\|Denmark\|Estonia\|France\|Germany\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Lithuania\|Netherlands\|New Zealand\|Peru\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Singapore\|Slovakia\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Australia\|Belgium\|Brazil\|Canada\|China\|France\|Germany\|Hong Kong\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Romania\|Russian Federation\|Spain\|Sweden\|Taiwan\|Thailand\|Turkey\|Ukraine\|Vietnam	1
United States\|Australia\|Belgium\|Brazil\|Canada\|France\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Netherlands\|Russian Federation\|Singapore\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Chile\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Poland\|Singapore\|Slovakia\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|United Kingdom\|Vietnam	1
United States\|Australia\|Belgium\|Canada\|China\|France\|Germany\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Puerto Rico\|Romania\|Russian Federation\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|China\|France\|Germany\|Hong Kong\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Portugal\|Romania\|Russian Federation\|Spain\|Taiwan\|Ukraine\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Singapore\|Spain\|Switzerland\|Taiwan	1
United States\|Australia\|Belgium\|Canada\|France\|Germany\|Hungary\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Russian Federation\|Spain\|Switzerland\|Taiwan\|Thailand\|Vietnam	1
United States\|Australia\|Belgium\|Canada\|France\|Germany\|Ireland\|Italy\|Poland\|Spain\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|France\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|New Zealand\|Norway\|Russian Federation\|Singapore\|Spain\|Sweden\|Taiwan\|Thailand\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Germany\|Spain	1
United States\|Australia\|Belgium\|Canada\|Greece\|Spain	1
United States\|Australia\|Belgium\|Canada\|Hong Kong\|Italy\|Netherlands\|Singapore\|Spain	1
United States\|Australia\|Belgium\|China\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Singapore\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Belgium\|Croatia\|Poland\|Romania\|Russian Federation	1
United States\|Australia\|Belgium\|Denmark\|France\|Germany\|Italy\|Korea, Republic of\|Luxembourg\|Netherlands\|Russian Federation\|Singapore\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Belgium\|France\|Germany\|Italy\|Korea, Republic of\|Poland\|Spain\|Sweden	1
United States\|Australia\|Belgium\|Greece\|Netherlands	1
United States\|Australia\|Bosnia and Herzegovina\|Brazil\|Canada\|Chile\|China\|Costa Rica\|Egypt\|France\|Germany\|Guatemala\|Hong Kong\|Israel\|Italy\|Korea, Republic of\|Mexico\|New Zealand\|Poland\|Portugal\|Russian Federation\|Serbia\|Singapore\|Spain\|Switzerland\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Australia\|Brazil\|Bulgaria\|Canada\|China\|France\|Hungary\|Italy\|Japan\|Korea, Republic of\|Netherlands\|New Zealand\|Poland\|Romania\|Singapore\|Spain\|Taiwan\|Ukraine	1
United States\|Australia\|Brazil\|Bulgaria\|Chile\|Croatia\|Czechia\|France\|Germany\|Greece\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Netherlands\|Philippines\|Poland\|Romania\|Russian Federation\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine	1
United States\|Australia\|Brazil\|Canada\|China\|France\|Germany\|Hong Kong\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Brazil\|Canada\|Hong Kong\|Korea, Republic of\|Poland\|Puerto Rico\|Singapore\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Brazil\|Czech Republic\|Russian Federation\|Singapore	1
United States\|Australia\|Bulgaria	1
United States\|Australia\|Canada\|China\|Colombia\|Estonia\|France\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Mexico\|Poland\|Russian Federation\|Taiwan\|Turkey\|Ukraine	1
United States\|Australia\|Canada\|China\|France\|Italy\|Japan\|Korea, Republic of\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Canada\|Colombia\|France\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Puerto Rico\|Russian Federation\|Spain\|United Kingdom	1
United States\|Australia\|Canada\|Czech Republic\|France\|Greece\|Hungary\|Israel\|Poland\|Russian Federation\|United Kingdom	1
United States\|Australia\|Canada\|Czechia\|France\|Germany\|Greece\|Italy\|Netherlands\|United Kingdom	1
United States\|Australia\|Canada\|Czechia\|Hungary\|Italy\|Spain\|United Kingdom	1
United States\|Australia\|Canada\|Denmark\|France\|Germany\|Hong Kong\|Israel\|Italy\|Japan\|Korea, Republic of\|Singapore\|Spain\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Australia\|Canada\|Finland\|France\|Germany\|Italy\|Norway\|Poland\|Spain\|Sweden	1
United States\|Australia\|Canada\|France\|Germany\|Italy\|Korea, Republic of\|Norway\|Singapore\|Spain\|Taiwan	1
United States\|Australia\|Canada\|Hong Kong\|Ireland\|Italy\|Japan\|Korea, Republic of\|Poland\|Russian Federation\|Singapore\|South Africa\|Spain\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Australia\|Canada\|Hungary\|Italy\|Korea, Republic of\|Poland\|Taiwan\|United Kingdom	1
United States\|Australia\|Canada\|Israel\|Korea, Republic of	1
United States\|Australia\|Chile\|Croatia\|France\|Germany\|Italy\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|Serbia\|Ukraine	1
United States\|Australia\|China	1
United States\|Australia\|China\|Hungary\|Korea, Republic of\|Netherlands\|Poland\|Russian Federation\|Taiwan\|Thailand\|Turkey\|Vietnam	1
United States\|Australia\|Czech Republic\|France\|Germany\|Hungary\|Poland	1
United States\|Australia\|France\|Germany\|Hungary\|Italy\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|Spain\|Taiwan\|Ukraine	1
United States\|Australia\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|France\|Germany\|Italy\|Netherlands\|Singapore\|Spain\|Switzerland	1
United States\|Australia\|France\|Germany\|Korea, Republic of\|New Zealand\|Poland\|Russian Federation\|Spain\|United Kingdom	1
United States\|Australia\|France\|Israel\|Korea, Republic of\|Spain\|United Kingdom	1
United States\|Australia\|France\|Italy\|Japan	1
United States\|Australia\|Germany	1
United States\|Australia\|Germany\|Italy\|United Kingdom	1
United States\|Australia\|Hong Kong\|Korea, Republic of\|Singapore\|Taiwan	1
United States\|Australia\|Hungary\|Israel\|Poland\|Russian Federation\|United Kingdom	1
United States\|Australia\|Italy\|Singapore\|Spain	1
United States\|Australia\|Japan\|Korea, Republic of\|Spain	1
United States\|Australia\|New Zealand\|Poland\|Thailand	1
United States\|Australia\|Puerto Rico\|South Africa	1
United States\|Australia\|Spain\|United Kingdom	1
United States\|Austria\|Belgium\|Canada\|Czechia\|France\|Germany\|Italy\|Netherlands\|Poland\|Spain\|Switzerland	1
United States\|Austria\|Belgium\|Canada\|Finland\|France\|Germany\|Italy\|Netherlands\|Poland\|Portugal\|Spain\|Switzerland\|United Kingdom	1
United States\|Austria\|Belgium\|China\|Denmark\|Finland\|France\|Germany\|Greece\|Hungary\|India\|Ireland\|Japan\|Korea, Republic of\|Mexico\|Poland\|Russian Federation\|Slovakia\|South Africa\|Spain\|Sweden\|Switzerland\|United Kingdom	1
United States\|Austria\|Belgium\|Korea, Republic of\|Poland\|Russian Federation\|Taiwan\|Thailand	1
United States\|Austria\|Canada\|France\|Germany\|Israel\|Italy\|Poland\|Spain	1
United States\|Austria\|Canada\|France\|Germany\|Israel\|Korea, Republic of	1
United States\|Austria\|Canada\|Germany\|Hungary\|Ireland\|Italy\|Portugal	1
United States\|Austria\|China\|Czechia\|France\|Georgia\|Greece\|Ireland\|Italy\|Korea, Republic of\|Lithuania\|Malaysia\|Poland\|Russian Federation\|Slovakia\|Thailand\|Ukraine	1
United States\|Austria\|France\|Hungary\|Italy\|Poland\|Romania\|Spain	1
United States\|Austria\|Germany	1
United States\|Belarus\|Belgium\|Canada\|Czechia\|France\|Germany\|Hungary\|Italy\|Netherlands\|Poland\|Russian Federation\|Serbia\|Slovenia\|Spain\|Ukraine	1
United States\|Belarus\|Bosnia and Herzegovina\|Bulgaria\|Croatia\|Georgia\|Germany\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Peru\|Philippines\|Poland\|Romania\|Russian Federation\|Serbia\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine\|Vietnam	1
United States\|Belgium\|Brazil\|Bulgaria\|Canada\|Czechia\|France\|Hungary\|Italy\|Mexico\|Peru\|Spain	1
United States\|Belgium\|Canada\|China\|France\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Taiwan\|Thailand\|United Kingdom	1
United States\|Belgium\|Canada\|Czechia\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Singapore\|Spain	1
United States\|Belgium\|Canada\|France\|Germany\|Hong Kong\|Ireland\|Israel\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Netherlands\|Portugal\|Russian Federation\|Singapore\|Spain\|Switzerland\|Turkey\|United Kingdom	1
United States\|Belgium\|Canada\|France\|Germany\|Israel\|Italy\|Spain	1
United States\|Belgium\|Canada\|France\|Germany\|Italy\|Korea, Republic of\|Poland\|Spain\|Sweden\|Thailand\|Turkey\|United Kingdom	1
United States\|Belgium\|Canada\|France\|Israel\|Italy\|Netherlands\|Spain	1
United States\|Belgium\|Canada\|Germany\|Poland\|United Kingdom	1
United States\|Belgium\|Canada\|Spain	1
United States\|Belgium\|China\|France\|Hong Kong\|Japan\|Korea, Republic of\|Malaysia\|Netherlands\|Russian Federation\|Singapore\|Spain\|Taiwan\|Thailand\|Vietnam	1
United States\|Belgium\|China\|Greece\|Korea, Republic of\|Portugal\|Spain\|Ukraine	1
United States\|Belgium\|Czechia\|Hungary\|Italy\|Korea, Republic of\|United Kingdom	1
United States\|Belgium\|Denmark\|France\|Hungary	1
United States\|Belgium\|France	1
United States\|Belgium\|France\|Germany\|Greece\|Israel\|Netherlands\|Spain	1
United States\|Belgium\|France\|Germany\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Spain\|United Kingdom	1
United States\|Belgium\|France\|Germany\|Italy\|Japan\|Poland\|Spain	1
United States\|Belgium\|France\|Germany\|Italy\|Netherlands\|Romania\|Spain	1
United States\|Belgium\|France\|Italy\|Spain\|Taiwan\|Turkey	1
United States\|Belgium\|France\|Korea, Republic of\|Spain	1
United States\|Belgium\|France\|Netherlands\|United Kingdom	1
United States\|Belgium\|Germany\|Israel\|Italy\|Netherlands\|Poland\|Spain\|United Kingdom	1
United States\|Belgium\|Germany\|Italy\|Poland\|United Kingdom	1
United States\|Belgium\|Korea, Republic of\|Netherlands\|Taiwan\|United Kingdom	1
United States\|Belgium\|United Kingdom	1
United States\|Brazil	1
United States\|Brazil\|Argentina\|Australia\|Austria\|Belgium\|Bulgaria\|Canada\|Chile\|France\|Germany\|Italy\|Japan\|Latvia\|Lithuania\|Mexico\|Netherlands\|Peru\|Portugal\|Russian Federation\|Singapore\|Slovakia\|Spain\|Switzerland\|Taiwan\|Ukraine	1
United States\|Brazil\|Bulgaria\|Canada\|China\|Czech Republic\|France\|Hungary\|Italy\|Korea, Republic of\|Latvia\|Lithuania\|Netherlands\|Poland\|Romania\|Slovakia\|South Africa\|Taiwan\|Thailand\|Ukraine	1
United States\|Brazil\|Bulgaria\|China\|Germany\|Hong Kong\|Hungary\|Japan\|Korea, Republic of\|Mexico\|Peru\|Poland\|Russian Federation\|South Africa\|Taiwan\|Thailand\|Ukraine\|United Kingdom\|Vietnam	1
United States\|Brazil\|Bulgaria\|France\|Germany\|Hungary\|Netherlands\|Poland	1
United States\|Brazil\|Canada\|Germany\|Korea, Republic of\|Poland\|Romania\|Russian Federation\|United Kingdom	1
United States\|Bulgaria\|Hungary\|Russian Federation\|Serbia	1
United States\|Bulgaria\|Romania	1
United States\|Canada\|Chile	1
United States\|Canada\|China\|France\|Hong Kong\|Japan\|Korea, Republic of\|Singapore\|Spain\|Taiwan	1
United States\|Canada\|Czech Republic\|Korea, Republic of\|United Kingdom	1
United States\|Canada\|Denmark\|France\|Russian Federation	1
United States\|Canada\|France	1
United States\|Canada\|France\|Germany\|Greece\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Romania\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Canada\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|United Kingdom	1
United States\|Canada\|France\|Germany\|Hungary\|Japan\|Poland	1
United States\|Canada\|France\|Germany\|Hungary\|Spain	1
United States\|Canada\|France\|Germany\|Korea, Republic of\|Netherlands\|Norway\|Singapore\|Spain\|Turkey	1
United States\|Canada\|France\|Hong Kong\|Italy\|Poland\|Portugal\|Spain\|Taiwan	1
United States\|Canada\|France\|Italy\|Portugal\|Spain\|Switzerland	1
United States\|Canada\|France\|Korea, Republic of\|Spain	1
United States\|Canada\|France\|Mexico\|Netherlands\|Spain\|Taiwan	1
United States\|Canada\|France\|Singapore\|Taiwan	1
United States\|Canada\|Germany\|Israel\|Italy\|Spain	1
United States\|Canada\|Germany\|Israel\|Netherlands\|Spain	1
United States\|Canada\|Germany\|Japan\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Taiwan	1
United States\|Canada\|Hong Kong	1
United States\|Canada\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Spain\|Taiwan	1
United States\|Canada\|Hong Kong\|Korea, Republic of\|Singapore\|Thailand	1
United States\|Canada\|Hungary\|India\|Netherlands\|Poland\|Serbia\|United Kingdom	1
United States\|Canada\|Hungary\|Israel\|Spain	1
United States\|Canada\|Hungary\|Italy\|Netherlands\|Poland\|Romania\|Spain	1
United States\|Canada\|Hungary\|Poland\|Russian Federation\|Slovakia	1
United States\|Canada\|Ireland\|Peru\|South Africa	1
United States\|Canada\|Israel	1
United States\|Canada\|Israel\|Italy\|Poland\|Romania\|Russian Federation\|Serbia\|Spain\|Switzerland\|Ukraine\|United Kingdom	1
United States\|Canada\|Italy\|Spain	1
United States\|Canada\|Japan\|Korea, Republic of\|Poland\|Russian Federation\|Taiwan\|Ukraine	1
United States\|Canada\|Japan\|Romania\|South Africa	1
United States\|Canada\|Poland	1
United States\|Canada\|Poland\|Portugal\|Spain\|United Kingdom	1
United States\|Canada\|Saudi Arabia	1
United States\|Canada\|Switzerland	1
United States\|China\|Germany\|Italy\|Japan\|Korea, Republic of\|Spain\|Taiwan\|United Kingdom	1
United States\|Czech Republic\|France\|Poland\|Spain\|United Kingdom	1
United States\|Czech Republic\|Greece\|Hungary\|Netherlands\|Slovakia	1
United States\|Czech Republic\|Hungary	1
United States\|Czechia\|France\|Germany\|Hungary\|Israel\|Italy\|Poland\|Spain\|United Kingdom	1
United States\|Denmark\|Japan\|Korea, Republic of\|Netherlands\|Norway\|Spain\|Sweden	1
United States\|Denmark\|Russian Federation	1
United States\|Estonia\|France\|Germany\|Japan\|Korea, Republic of\|Poland\|Russian Federation\|United Kingdom	1
United States\|Finland\|France\|Germany\|India\|Italy\|South Africa\|Spain\|Thailand	1
United States\|France\|Germany\|Greece\|Hungary\|Japan\|Netherlands\|Russian Federation\|Spain\|Taiwan\|Turkey	1
United States\|France\|Germany\|Greece\|Italy\|Spain	1
United States\|France\|Germany\|India\|Italy\|Poland\|Russian Federation\|Ukraine	1
United States\|France\|Germany\|Italy	1
United States\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Norway\|Spain\|Taiwan\|United Kingdom	1
United States\|France\|Germany\|Italy\|Korea, Republic of\|Portugal	1
United States\|France\|Germany\|Italy\|Spain\|United Kingdom	1
United States\|France\|Germany\|Japan\|Korea, Republic of\|Malaysia\|Spain\|Taiwan	1
United States\|France\|Germany\|Japan\|Spain\|United Kingdom	1
United States\|France\|Germany\|Korea, Republic of\|Spain\|Taiwan	1
United States\|France\|Greece\|Hungary\|Italy\|Korea, Republic of\|Netherlands\|Spain	1
United States\|France\|Hong Kong\|Korea, Republic of\|Spain\|United Kingdom	1
United States\|France\|Israel\|Japan\|United Kingdom	1
United States\|France\|Israel\|Luxembourg\|Spain	1
United States\|France\|Israel\|Spain\|Taiwan	1
United States\|France\|Italy\|Japan\|Poland\|Spain	1
United States\|France\|Italy\|Korea, Republic of\|Spain\|Taiwan	1
United States\|France\|Italy\|Spain	1
United States\|France\|Italy\|Taiwan\|United Kingdom	1
United States\|France\|Japan\|Netherlands\|Spain	1
United States\|France\|Japan\|Spain	1
United States\|France\|Korea, Republic of\|Serbia\|Spain\|Taiwan	1
United States\|France\|Korea, Republic of\|Spain\|Taiwan	1
United States\|France\|Korea, Republic of\|Spain\|Turkey	1
United States\|France\|Netherlands	1
United States\|France\|Netherlands\|Spain	1
United States\|France\|Spain	1
United States\|France\|Spain\|United Kingdom	1
United States\|Germany\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|Chile\|Colombia\|Czech Republic\|Denmark\|Greece\|Hong Kong\|Hungary\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Poland\|Russian Federation\|Slovakia\|Spain\|Switzerland\|Taiwan\|Thailand\|United Kingdom	1
United States\|Germany\|Hong Kong\|Japan	1
United States\|Germany\|Hungary\|Romania	1
United States\|Germany\|India\|Korea, Republic of	1
United States\|Germany\|Italy\|Korea, Republic of\|Poland\|Spain\|Switzerland	1
United States\|Germany\|Italy\|Spain\|United Kingdom	1
United States\|Germany\|Japan\|Korea, Republic of\|Puerto Rico	1
United States\|Germany\|Korea, Republic of\|Mexico\|Poland\|Russian Federation	1
United States\|Germany\|Korea, Republic of\|Netherlands\|Spain\|Taiwan\|United Kingdom	1
United States\|Germany\|Latvia\|Poland\|Russian Federation\|Ukraine	1
United States\|Germany\|Puerto Rico	1
United States\|Germany\|Spain	1
United States\|Hong Kong\|Korea, Republic of\|Malaysia\|Singapore\|Taiwan\|Thailand	1
United States\|Hong Kong\|Korea, Republic of\|Singapore\|Taiwan	1
United States\|Hong Kong\|Netherlands\|Singapore\|Taiwan	1
United States\|Hungary\|Italy\|Korea, Republic of\|Poland\|Russian Federation\|Spain\|Taiwan	1
United States\|Hungary\|Korea, Republic of\|Romania\|Russian Federation\|Taiwan	1
United States\|Hungary\|Poland\|Russian Federation	1
United States\|India\|Poland\|Romania	1
United States\|India\|United Kingdom	1
United States\|Israel\|Japan\|Spain	1
United States\|Israel\|Spain	1
United States\|Italy\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|China\|Czech Republic\|Denmark\|France\|Germany\|Greece\|Hong Kong\|Hungary\|India\|Ireland\|Israel\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Portugal\|Romania\|Russian Federation\|Singapore\|Slovakia\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Italy\|Japan\|Poland\|Romania\|Russian Federation\|Spain\|Switzerland\|Taiwan\|Ukraine\|United Kingdom	1
United States\|Italy\|Korea, Republic of\|Malaysia\|Spain	1
United States\|Italy\|Korea, Republic of\|Spain	1
United States\|Italy\|Korea, Republic of\|Taiwan	1
United States\|Italy\|Lithuania	1
United States\|Italy\|Spain	1
United States\|Japan\|Korea, Republic of	1
United States\|Japan\|Korea, Republic of\|Spain\|Taiwan	1
United States\|Japan\|Spain	1
United States\|Japan\|Taiwan	1
United States\|Korea, Republic of\|Netherlands\|Spain\|Taiwan\|United Kingdom	1
United States\|Korea, Republic of\|Spain\|Taiwan	1
United States\|Korea, Republic of\|Taiwan	1
United States\|Norway\|United Kingdom	1
United States\|Puerto Rico\|South Africa	1
United States\|Russian Federation\|Ukraine	1
United States\|South Africa	1
United States\|Spain\|Austria\|Canada\|France\|Germany	1
United States\|Switzerland	1

Sites per Study

Site_count	Study_Count
1	919
2	164
3	86
4	80
5	79
6	32
7	55
8	38
9	34
10	36
11	31
12	34
13	30
14	17
15	24
16	28
17	18
18	10
19	21
20	22
21	18
22	11
23	11
24	15
25	13
26	10
27	8
28	6
29	6
30	16
31	9
32	10
33	11
34	4
35	7
36	5
37	8
38	10
39	3
40	5
41	3
42	10
43	4
44	10
45	3
46	4
47	8
48	3
49	1
50	5
51	4
52	7
53	2
54	2
55	2
56	4
57	3
58	2
59	5
60	6
61	1
62	2
63	2
64	3
65	5
66	2
67	2
68	2
69	7
70	3
71	4
72	3
73	3
74	3
75	2
76	1
77	1
78	3
79	3
80	2
81	1
82	1
84	5
85	3
86	3
87	3
88	2
89	1
90	2
91	3
92	3
93	3
94	4
96	1
97	2
98	1
99	1
101	4
103	1
105	2
106	1
108	1
109	1
110	3
111	1
112	1
113	2
114	2
115	1
116	2
117	2
118	2
119	2
120	1
121	1
122	1
123	4
124	3
125	1
126	1
127	1
129	1
132	1
133	5
134	1
135	1
136	1
137	1
139	1
140	1
141	4
143	2
144	1
145	2
146	1
147	2
150	1
151	1
153	1
154	4
155	2
156	1
157	4
160	1
161	1
162	1
163	1
166	1
167	3
170	1
175	1
179	1
181	1
182	3
183	1
185	1
186	1
187	1
188	2
189	2
192	2
197	1
198	1
199	1
202	1
204	1
207	1
208	1
210	1
212	1
213	2
216	1
223	1
224	3
227	1
231	2
233	1
237	1
240	2
242	1
247	2
248	1
249	1
257	1
260	1
263	1
264	2
271	1
279	1
287	1
295	2
301	1
305	1
329	1
339	1
348	1
369	2
373	1
386	1
468	1
484	1
532	1
544	1
605	1
638	1
658	1
743	1
873	1
892	1
931	1
1175	1
1498	2

Phase

Phase	Study_Count
Phase 2	1012
Phase 1	426
Phase 3	359
Phase 1/Phase 2	228
N/A	179
Phase 4	43
Phase 2/Phase 3	28
Early Phase 1	16

Number of Arms

Number_of_Arms	Count_of_Studies
1	944
2	797
3	150
4	80
5	23
6	19
7	10
8	5
9	8
10	5
11	2
12	1
13	1
14	2
15	1
16	1
18	2
19	1
24	1
NA	238

Number of Updates

Count of Versions	Count of Studies
1	99
2	169
3	181
4	137
5	131
6	118
7	74
8	99
9	92
10	88
11	85
12	74
13	61
14	59
15	58
16	45
17	24
18	46
19	40
20	30
21	23
22	26
23	16
24	18
25	30
26	25
27	27
28	16
29	14
30	13
31	12
32	9
33	10
34	14
35	9
36	7
37	9
38	6
39	9
40	9
41	4
42	4
43	8
44	10
45	11
46	10
47	8
48	4
49	4
50	9
51	5
52	7
53	3
54	5
55	9
56	7
57	4
58	7
59	3
60	6
61	7
62	2
63	5
64	5
65	5
66	2
67	3
68	3
69	4
70	7
71	2
72	3
73	5
74	2
75	6
76	4
77	3
78	2
79	3
80	3
81	1
82	4
84	5
85	1
86	5
87	2
88	3
89	3
90	1
91	1
92	1
93	4
96	1
97	2
98	1
99	1
100	2
102	1
104	1
105	1
106	3
110	1
117	1
120	1
121	1
124	1
125	1
126	1
131	2
139	1
141	2
144	1
150	1
155	1
163	1
169	1
190	1
202	1
205	1
216	1
249	1
277	1
370	1
424	1
456	1
473	1
552	1
567	1
703	1
1518	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	44063	2192	20.101734
Contacts/Locations	24048	2004	12.000000
Recruitment Status	4180	1988	2.102616
Study Design	3770	1594	2.365119
Arms	3183	1314	2.422374
Interventions	3183	1314	2.422374
Eligibility	3142	1358	2.313697
Outcome Measures	2932	1295	2.264093
Study Identification	2887	1276	2.262539
Study Description	2402	1071	2.242764
None (earliest Version on record)	2291	2291	1.000000
Sponsor/Collaborators	1974	1087	1.816007
Oversight	1589	1120	1.418750
Conditions	1519	792	1.917929
More Information	1293	347	3.726225
References	974	520	1.873077
Results	465	465	1.000000
IPDSharing	368	301	1.222591
Baseline Characteristics	253	187	1.352941
Reported Adverse Events	192	164	1.170732
Participant Flow	173	146	1.184932
Results Submission Events	128	128	1.000000
Documents	111	99	1.121212
2020 Study Status	1	1	1.000000
Quality Control Review has not concludedReturned: February 7	1	1	1.000000

Enrollment Metrics by Phase

Measure	Early.Phase.1	N.A	Phase.1	Phase.1.Phase.2	Phase.2	Phase.2.Phase.3	Phase.3	Phase.4
Min.	3.0	3.000	1.00000	2.0000	1.00000	40.0000	1.0000	5.0000
1st Qu.	12.0	29.000	18.00000	40.0000	40.00000	116.0000	275.7500	53.0000
Median	22.5	56.000	31.50000	70.0000	65.00000	187.0000	453.5000	107.5000
Mean	32.5	444.226	60.50474	104.0721	97.49847	634.7857	550.4119	384.6905
3rd Qu.	32.0	150.000	56.75000	122.5000	120.00000	409.7500	671.5000	195.0000
Max.	180.0	39981.000	1260.00000	970.0000	1805.00000	10000.0000	5000.0000	6586.0000

Trial Group Type

group_type	Group_Count
Experimental	3076
Active Comparator	566
NA	238
Placebo Comparator	165
Other	99
No Intervention	45
Sham Comparator	3

Intervention Model

intervention_model	Study_Count
Single Group Assignment	1111
Parallel Assignment	997
NA	93
Sequential Assignment	57
Crossover Assignment	26
Factorial Assignment	7

Primary Purpose

primary_purpose	Study_Count
Treatment	2120
Diagnostic	62
Supportive Care	34
Other	30
Prevention	13
Basic Science	11
NA	8
Health Services Research	6
Screening	6
Device Feasibility	1

Observational Studies

Studies by Country

Country	Study_Count
China	59
United States	54
France	29
NA	19
Germany	12
Netherlands	11
Spain	10
Korea, Republic of	9
Japan	8
Taiwan	8
Canada	7
Italy	6
Denmark	5
United Kingdom	5
Belgium	4
Greece	4
United States\|Canada	4
Mexico	3
Poland	3
Singapore	3
Austria	2
Brazil	2
Egypt	2
Ireland	2
Russian Federation	2
Argentina	1
Argentina\|Chile\|Colombia\|Dominican Republic\|India\|Mexico\|Peru\|Taiwan\|Thailand\|Uruguay	1
Argentina\|Chile\|Colombia\|Uruguay	1
Australia	1
Australia\|Belgium\|France\|Germany\|Israel\|Italy\|Netherlands\|Norway\|Switzerland\|United Kingdom	1
Australia\|New Zealand\|Singapore	1
Austria\|Belgium\|Denmark\|Germany\|Greece\|Hungary\|Italy\|Lithuania\|Luxembourg\|Netherlands\|Spain\|Sweden\|United Kingdom	1
Austria\|Belgium\|Germany\|Spain\|Switzerland	1
Bahrain\|Qatar\|United Arab Emirates	1
Belgium\|France\|Germany\|Greece\|Italy\|Portugal\|Spain\|Turkey	1
China\|Japan\|Korea, Republic of	1
Czechia\|Germany\|Poland\|Spain\|Switzerland\|United Kingdom	1
Egypt\|Lebanon\|Morocco\|Saudi Arabia\|United Arab Emirates	1
Finland	1
Germany\|Austria	1
Hong Kong\|Korea, Republic of\|Malaysia\|Singapore	1
Hungary	1
India	1
Jordan	1
Kazakhstan	1
Korea, Republic of\|Singapore	1
Norway	1
Serbia	1
Sweden	1
United States\|Austria\|Canada\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Mexico\|Poland\|Singapore\|Spain\|Taiwan	1
United States\|Bolivia\|Mexico\|Peru\|Venezuela	1
United States\|Denmark	1

Sites per Study

Site_count	Study_Count
1	177
2	9
3	8
4	7
5	10
6	3
7	3
8	3
9	5
10	9
11	5
12	2
13	1
14	4
15	2
17	2
18	1
21	1
22	2
23	4
24	2
25	1
26	1
28	1
29	2
31	2
32	2
33	2
35	1
37	1
39	1
41	1
42	1
43	1
44	1
46	1
50	1
56	1
61	1
63	1
71	1
72	1
73	1
81	1
88	1
92	1
101	1
111	1
118	1
133	1
145	1
152	1
170	1
198	1
299	1
405	1
432	1

Number of Updates

Count of Versions	Count of Studies
1	40
2	54
3	38
4	27
5	15
6	20
7	11
8	9
9	5
10	8
11	11
12	4
13	4
14	1
15	2
16	5
17	1
19	2
20	1
21	3
22	1
23	1
25	1
26	1
27	2
28	1
32	1
34	1
37	1
40	1
44	1
47	1
49	2
50	1
54	2
55	1
56	1
60	2
63	2
64	2
66	1
67	1
68	1
69	1
70	2
78	1
82	2
83	1
84	1
131	1
500	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	3621	260	13.926923
Contacts/Locations	1528	212	7.207547
Recruitment Status	347	204	1.700980
Study Design	311	167	1.862275
None (earliest Version on record)	300	300	1.000000
Study Description	236	90	2.622222
Eligibility	159	95	1.673684
Outcome Measures	122	92	1.326087
Study Identification	110	69	1.594203
Sponsor/Collaborators	99	77	1.285714
Conditions	94	53	1.773585
Groups	94	56	1.678571
Interventions	94	56	1.678571
Oversight	67	61	1.098361
References	52	34	1.529412
IPDSharing	16	14	1.142857
Results	16	16	1.000000
More Information	8	5	1.600000
Documents	7	7	1.000000
Results Submission Events	4	4	1.000000
Baseline Characteristics	1	1	1.000000
Participant Flow	1	1	1.000000

Enrollment Metrics

Measure	Observational
Min	1.0000
1st Qu	70.0000
Median	160.5000
Mean	781.3209
3rd Qu	503.2500
Max	50000.0000

Observation Model

observational_model	Study_Count
Cohort	188
Case-Only	66
Other	17
NA	10
Case-Control	9
Case Control	6
Case-Crossover	2
Defined Population	1
Ecologic or Community	1

Time Perspective

time_perspective	Study_Count
Prospective	188
Retrospective	87
Cross-Sectional	14
Other	7
NA	3
Longitudinal, Prospective	1

Registries

Studies by Country

Country	Study_Count
China	7
Korea, Republic of	3
Belgium	2
Germany	2
Greece	2
Japan	2
NA	2
Denmark\|Norway	1
Egypt	1
France	1
Netherlands	1
United Kingdom	1
United States	1

Sites per Study

Site_count	Study_Count
1	20
2	1
5	1
8	1
34	1
44	1
73	1

Number of Updates

Count of Versions	Count of Studies
1	2
2	12
3	1
4	2
5	2
6	1
8	1
9	1
10	2
18	1
41	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	123	24	5.125000
Contacts/Locations	67	17	3.941177
None (earliest Version on record)	26	26	1.000000
Recruitment Status	22	17	1.294118
Study Design	13	11	1.181818
Sponsor/Collaborators	8	3	2.666667
Study Identification	8	6	1.333333
Eligibility	7	5	1.400000
Study Description	6	6	1.000000
Outcome Measures	5	5	1.000000
Conditions	2	2	1.000000
Groups	2	2	1.000000
Interventions	2	2	1.000000
Oversight	2	2	1.000000
IPDSharing	1	1	1.000000

Enrollment Metrics

Measure	Registries
Min	20.000
1st Qu	132.000
Median	315.000
Mean	1034.808
3rd Qu	989.000
Max	7500.000

Registry Model

observational_model	Study_Count
Cohort	20
Other	4
Case-Only	2

Time Perspective

time_perspective	Study_Count
Prospective	21
Other	5

Follow-up

target_duration	Study_Count
3 Years	11
5 Years	4
1 Year	2
24 Months	2
1 Day	1
12 Months	1
2 Years	1
20 Months	1
36 Months	1
4 Months	1
7 Years	1

intervention_type	Study_Count
Drug	1310
Drug\|placebo	143
Drug\|Radiation	118
Biological\|Drug	107
Biological	82
Radiation	75
Drug\|Other	59
Procedure	48
Drug\|Procedure	43
Other	35
Biological\|Drug\|Other	21
Device	18
Drug\|Procedure\|Radiation	18
Behavioral	13
Biological\|Drug\|placebo	13
Biological\|Drug\|Radiation	11
Biological\|Other	11
Diagnostic Test	10
Drug\|Other\|placebo	9
Drug\|Other\|Procedure	9
Drug\|Other\|Radiation	8
Drug\|placebo\|Radiation	8
Other\|Procedure	8
Procedure\|Radiation	8
Biological\|placebo	7
Device\|Drug	7
Biological\|Radiation	6
Other\|Radiation	6
Combination Product	5
Other\|Procedure\|Radiation	5
Dietary Supplement	4
Behavioral\|Other\|Procedure	3
Biological\|Other\|Radiation	3
Diagnostic Test\|Drug	3
Drug\|Genetic\|Other	3
Drug\|Other\|Procedure\|Radiation	3
Genetic	3
Behavioral\|Drug\|placebo	2
Biological\|Dietary Supplement\|Drug	2
Biological\|Drug\|Other\|placebo	2
Biological\|Drug\|Other\|Radiation	2
Biological\|Other\|Procedure\|Radiation	2
Device\|Drug\|Radiation	2
Device\|Other	2
Dietary Supplement\|Drug	2
Drug\|Genetic\|Other\|Procedure	2
Behavioral\|Drug\|Other\|placebo	1
Behavioral\|Drug\|Other\|Procedure	1
Behavioral\|Radiation	1
Biological\|Combination Product\|Drug\|Other	1
Biological\|Device	1
Biological\|Device\|Drug\|Radiation	1
Biological\|Diagnostic Test	1
Biological\|Drug\|Genetic\|Other	1
Biological\|Drug\|Other\|Procedure	1
Biological\|Drug\|placebo\|Radiation	1
Biological\|Drug\|Procedure	1
Biological\|placebo\|Radiation	1
Biological\|Procedure	1
Combination Product\|Drug	1
Combination Product\|Other	1
Device\|Drug\|Other	1
Device\|Drug\|Other\|Procedure	1
Device\|Drug\|Procedure\|Radiation	1
Device\|Other\|Radiation	1
Device\|Procedure	1
Device\|Radiation	1
Diagnostic Test\|Drug\|Other	1
Diagnostic Test\|Other\|Procedure	1
Dietary Supplement\|Drug\|Radiation	1
Dietary Supplement\|placebo	1
Drug\|Genetic	1
Drug\|Genetic\|Other\|placebo	1
Drug\|Genetic\|Other\|Procedure\|Radiation	1
Drug\|Genetic\|Procedure	1
Drug\|Other\|placebo\|Procedure	1

Number_of_Arms	Count_of_Studies
1	944
2	797
3	150
4	80
5	23
6	19
7	10
8	5
9	8
10	5
11	2
12	1
13	1
14	2
15	1
16	1
18	2
19	1
24	1
NA	238

Site_count	Study_Count
1	177
2	9
3	8
4	7
5	10
6	3
7	3
8	3
9	5
10	9
11	5
12	2
13	1
14	4
15	2
17	2
18	1
21	1
22	2
23	4
24	2
25	1
26	1
28	1
29	2
31	2
32	2
33	2
35	1
37	1
39	1
41	1
42	1
43	1
44	1
46	1
50	1
56	1
61	1
63	1
71	1
72	1
73	1
81	1
88	1
92	1
101	1
111	1
118	1
133	1
145	1
152	1
170	1
198	1
299	1
405	1
432	1

Count of Versions	Count of Studies
1	40
2	54
3	38
4	27
5	15
6	20
7	11
8	9
9	5
10	8
11	11
12	4
13	4
14	1
15	2
16	5
17	1
19	2
20	1
21	3
22	1
23	1
25	1
26	1
27	2
28	1
32	1
34	1
37	1
40	1
44	1
47	1
49	2
50	1
54	2
55	1
56	1
60	2
63	2
64	2
66	1
67	1
68	1
69	1
70	2
78	1
82	2
83	1
84	1
131	1
500	1

Number_of_Arms	Count_of_Studies
1	944
2	797
3	150
4	80
5	23
6	19
7	10
8	5
9	8
10	5
11	2
12	1
13	1
14	2
15	1
16	1
18	2
19	1
24	1
NA	238

Site_count	Study_Count
1	177
2	9
3	8
4	7
5	10
6	3
7	3
8	3
9	5
10	9
11	5
12	2
13	1
14	4
15	2
17	2
18	1
21	1
22	2
23	4
24	2
25	1
26	1
28	1
29	2
31	2
32	2
33	2
35	1
37	1
39	1
41	1
42	1
43	1
44	1
46	1
50	1
56	1
61	1
63	1
71	1
72	1
73	1
81	1
88	1
92	1
101	1
111	1
118	1
133	1
145	1
152	1
170	1
198	1
299	1
405	1
432	1

Count of Versions	Count of Studies
1	40
2	54
3	38
4	27
5	15
6	20
7	11
8	9
9	5
10	8
11	11
12	4
13	4
14	1
15	2
16	5
17	1
19	2
20	1
21	3
22	1
23	1
25	1
26	1
27	2
28	1
32	1
34	1
37	1
40	1
44	1
47	1
49	2
50	1
54	2
55	1
56	1
60	2
63	2
64	2
66	1
67	1
68	1
69	1
70	2
78	1
82	2
83	1
84	1
131	1
500	1

carcinoma, non-small-cell lung

Study Counts

Studies over Time

Interventional Trials

Intervention Type

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Studies by Country

Sites per Study

Phase

Number of Arms

Number of Updates

Update History Change Type

Enrollment Metrics by Phase

Trial Group Type

Intervention Model

Primary Purpose

Observational Studies

Studies by Country

Sites per Study

Number of Updates

Update History Change Type

Enrollment Metrics

Observation Model

Time Perspective

Registries

Studies by Country

Sites per Study

Number of Updates

Update History Change Type

Enrollment Metrics

Registry Model

Time Perspective

Follow-up

Number_of_Arms	Count_of_Studies
1	944
2	797
3	150
4	80
5	23
6	19
7	10
8	5
9	8
10	5
11	2
12	1
13	1
14	2
15	1
16	1
18	2
19	1
24	1
NA	238

Site_count	Study_Count
1	177
2	9
3	8
4	7
5	10
6	3
7	3
8	3
9	5
10	9
11	5
12	2
13	1
14	4
15	2
17	2
18	1
21	1
22	2
23	4
24	2
25	1
26	1
28	1
29	2
31	2
32	2
33	2
35	1
37	1
39	1
41	1
42	1
43	1
44	1
46	1
50	1
56	1
61	1
63	1
71	1
72	1
73	1
81	1
88	1
92	1
101	1
111	1
118	1
133	1
145	1
152	1
170	1
198	1
299	1
405	1
432	1

Count of Versions	Count of Studies
1	40
2	54
3	38
4	27
5	15
6	20
7	11
8	9
9	5
10	8
11	11
12	4
13	4
14	1
15	2
16	5
17	1
19	2
20	1
21	3
22	1
23	1
25	1
26	1
27	2
28	1
32	1
34	1
37	1
40	1
44	1
47	1
49	2
50	1
54	2
55	1
56	1
60	2
63	2
64	2
66	1
67	1
68	1
69	1
70	2
78	1
82	2
83	1
84	1
131	1
500	1